| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | DCAF1 FCRL2 ZSWIM8 DAB2 TAB2 IRS1 RAD54L2 BCOR SSBP3 SFR1 GAB2 JARID2 KMT2C TDRD3 JUP PER2 NFE2L2 ZMIZ2 NFKB1 TNRC6A FLRT3 TAPBP MAML3 WNK3 COL11A2 ANK3 MED16 HIPK2 GRB14 ATG14 SH2D2A ECPAS SEC22A CREBBP GRIP1 NCOR1 IGF2BP3 ITSN2 GAB3 GAB1 | 7.68e-06 | 1356 | 282 | 40 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DCAF1 FCRL2 ZSWIM8 DAB2 IRS1 RAD54L2 BCOR SSBP3 SFR1 GAB2 JARID2 KMT2C TDRD3 JUP PER2 NFE2L2 ZMIZ2 NFKB1 TNRC6A FLRT3 MAML3 WNK3 COL11A2 ANK3 MED16 HIPK2 GRB14 ATG14 SH2D2A SEC22A CREBBP GRIP1 NCOR1 IGF2BP3 GAB3 GAB1 | 7.69e-06 | 1160 | 282 | 36 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription factor binding | DCAF1 BBS2 BCOR RXRA MEF2D STAT5A JARID2 JUP PER2 NFATC3 NFE2L2 CHD6 TAF10 TAF1L FOXO3 CRTC3 MED16 HIPK2 NR4A3 RELA RUNX2 CREBBP PASD1 TBX18 NCOR1 ASCL1 TP53BP2 | 9.47e-06 | 753 | 282 | 27 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | DCAF1 BBS2 BCOR RXRA MEF2D STAT5A JUP PER2 NFE2L2 TAF10 TAF1L CRTC3 MED16 HIPK2 NR4A3 RELA RUNX2 CREBBP PASD1 TBX18 NCOR1 ASCL1 TP53BP2 | 9.65e-06 | 582 | 282 | 23 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | DCAF1 BBS2 RXRA MEF2D JUP PER2 NFE2L2 TAF10 TAF1L MED16 HIPK2 NR4A3 RELA CREBBP TBX18 NCOR1 TP53BP2 | 9.83e-05 | 417 | 282 | 17 | GO:0061629 |
| GeneOntologyMolecularFunction | actinin binding | 3.36e-04 | 43 | 282 | 5 | GO:0042805 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXJ2 ZNF148 BACH1 DAB2 IRF1 SSBP2 RAD54L2 SSBP3 RXRA MEF2D ALX4 STAT4 STAT5A KMT2C JUP NFATC3 NFE2L1 NFE2L2 ZMIZ2 NFKB1 CHD6 TAF10 MGA MAML3 SOX6 FOXO3 CRTC3 MED16 HIPK2 BAZ1B NR4A3 CHD8 RELA RUNX2 CREBBP TFR2 KLF10 LMO7 ASCL1 ASXL3 TBK1 ATM | 5.94e-07 | 1390 | 276 | 42 | GO:0045944 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | RIPOR2 NCKAP1 ABCA12 NAGLU BBS2 BCOR RXRA MEF2D ALX4 STAT5A HEG1 ALMS1 EDARADD NFKB1 SEC24B TAF10 USH2A FOXG1 IMPG2 SOX6 FOXO3 NDST1 FAT4 COL11A2 DSCAM FAT3 HIPK2 NR4A3 RELA RUNX2 TBX18 IGFBP5 BTBD7 ASXL3 ANKRD11 MEGF11 JHY | 6.81e-06 | 1269 | 276 | 37 | GO:0009887 |
| GeneOntologyCellularComponent | transcription regulator complex | BACH1 SSBP3 RXRA ALX4 STAT4 STAT5A PER2 NFATC3 NFE2L2 NFKB1 TAF10 MGA TAF1L SOX6 FOXO3 MED16 HIPK2 NR4A3 RELA RUNX2 CREBBP PASD1 TBX18 NCOR1 GTF2H2 ASCL1 | 1.65e-07 | 596 | 282 | 26 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | FOXJ2 ZHX3 KLF8 JADE3 BACH1 IRF1 KDM4E SFR1 RXRA MEF2D ALX4 STAT4 STAT5A JARID2 NFATC3 NFE2L1 NFE2L2 ZMIZ2 NFKB1 TPRX1 CHD6 TAF10 MGA TAF1L FOXG1 SOX6 FOXO3 BAZ1B NR4A3 CHD8 RELA RUNX2 CREBBP PHC1 TBX18 NCOR1 KLF10 ASCL1 ANKRD11 KDM4A ZHX1 AFF4 | 3.73e-06 | 1480 | 282 | 42 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 DCAF1 SART3 BACH1 INTS1 BCOR SFR1 RXRA STAT4 STAT5A DHX8 JARID2 KMT2C TDRD3 JUP PER2 UBAP2L NFE2L2 NFKB1 MAD1L1 TAF10 MGA TAF1L FOXO3 MED16 HIPK2 BAZ1B CHD8 RELA PRPF8 CREBBP PHC1 PASD1 TBX18 NCOR1 GTF2H2 ASCL1 ASXL3 AFF4 SYMPK | 3.75e-06 | 1377 | 282 | 40 | GO:0140513 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | BACH1 RXRA STAT4 STAT5A NFE2L2 TAF10 TAF1L MED16 HIPK2 CREBBP PASD1 GTF2H2 ASCL1 | 8.92e-05 | 272 | 282 | 13 | GO:0090575 |
| GeneOntologyCellularComponent | NF-kappaB p50/p65 complex | 1.81e-04 | 2 | 282 | 2 | GO:0035525 | |
| GeneOntologyCellularComponent | Cry-Per complex | 5.39e-04 | 3 | 282 | 2 | GO:1990512 | |
| Domain | p53-like_TF_DNA-bd | 1.11e-06 | 53 | 279 | 8 | IPR008967 | |
| Domain | PH_dom-like | RGPD4 DOK6 DAB2 IRS1 LYST GAB2 PTPN13 RABGAP1L FGD5 ARHGAP20 GRB14 ARHGAP9 CMIP ITSN2 GAB3 TNS1 GAB1 | 2.44e-04 | 426 | 279 | 17 | IPR011993 |
| Domain | Laminin_G_2 | 3.08e-04 | 40 | 279 | 5 | PF02210 | |
| Domain | JmjN | 3.66e-04 | 10 | 279 | 3 | SM00545 | |
| Domain | RHD_dimer | 3.66e-04 | 10 | 279 | 3 | PF16179 | |
| Domain | REL_1 | 3.66e-04 | 10 | 279 | 3 | PS01204 | |
| Domain | JmjN | 3.66e-04 | 10 | 279 | 3 | PF02375 | |
| Domain | NFkB/Dor | 3.66e-04 | 10 | 279 | 3 | IPR000451 | |
| Domain | RHD_DNA_bind_dom | 3.66e-04 | 10 | 279 | 3 | IPR011539 | |
| Domain | RHD_dimer | 3.66e-04 | 10 | 279 | 3 | IPR032397 | |
| Domain | - | 3.66e-04 | 10 | 279 | 3 | 2.60.40.340 | |
| Domain | JMJN | 3.66e-04 | 10 | 279 | 3 | PS51183 | |
| Domain | RHD_DNA_bind | 3.66e-04 | 10 | 279 | 3 | PF00554 | |
| Domain | REL_2 | 3.66e-04 | 10 | 279 | 3 | PS50254 | |
| Domain | JmjN | 3.66e-04 | 10 | 279 | 3 | IPR003349 | |
| Domain | FN3 | PRTG KIAA0319L NFASC PTPRD PTPRZ1 FLRT3 USH2A DSCAM MYOM2 OSMR | 4.81e-04 | 185 | 279 | 10 | SM00060 |
| Domain | LamG | 4.84e-04 | 44 | 279 | 5 | SM00282 | |
| Domain | - | 5.55e-04 | 95 | 279 | 7 | 2.60.120.200 | |
| Domain | Homez_dom | 6.60e-04 | 3 | 279 | 2 | IPR024578 | |
| Domain | FAM65_N | 6.60e-04 | 3 | 279 | 2 | IPR031780 | |
| Domain | Homez | 6.60e-04 | 3 | 279 | 2 | PF11569 | |
| Domain | PL48 | 6.60e-04 | 3 | 279 | 2 | PF15903 | |
| Domain | FAM65 | 6.60e-04 | 3 | 279 | 2 | IPR026136 | |
| Domain | SSDP_DNA-bd | 6.60e-04 | 3 | 279 | 2 | IPR008116 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.75e-07 | 65 | 197 | 9 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 2.48e-06 | 8 | 197 | 4 | M48024 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 4.41e-06 | 9 | 197 | 4 | MM1533 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.89e-06 | 49 | 197 | 7 | M41832 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 2.40e-05 | 13 | 197 | 4 | M22007 | |
| Pathway | WP_HEPATITIS_B_INFECTION | TAB2 STAT4 STAT5A NFATC3 NFKB1 RELA CREBBP TBK1 IRAK4 MAPK11 | 5.14e-05 | 151 | 197 | 10 | M39801 |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY | 7.63e-05 | 17 | 197 | 4 | M47912 | |
| Pathway | WP_PROLACTIN_SIGNALING | 9.05e-05 | 76 | 197 | 7 | M39601 | |
| Pathway | WP_IL4_SIGNALING | 1.02e-04 | 54 | 197 | 6 | M39720 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY | 1.50e-04 | 20 | 197 | 4 | M47563 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.53e-04 | 140 | 197 | 9 | M27484 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.84e-04 | 21 | 197 | 4 | M27485 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.22e-04 | 22 | 197 | 4 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.22e-04 | 22 | 197 | 4 | MM1443 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.66e-04 | 23 | 197 | 4 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.16e-04 | 24 | 197 | 4 | M13404 | |
| Pubmed | ZHX3 KLF8 ZNF148 ZMYM2 IRF1 SSBP2 RAD54L2 BCOR SSBP3 RXRA MEF2D STAT4 STAT5A KMT2C JUP ALMS1 NFATC3 UBAP2L ZMIZ2 NFKB1 RECQL5 SEC24B TNRC6A CHD6 HERC2 HERC1 TAF10 MGA TAF1L SOX6 RBM11 HIPK2 BAZ1B CHD8 RELA FIGN CREBBP NCOR1 IGF2BP3 KLF10 PAN3 CABIN1 ZHX1 SYMPK | 4.24e-14 | 1429 | 285 | 44 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 ERBB2 GAPVD1 NCKAP1 CEP85L BACH1 TAB2 IRS1 LYST NEK9 MEF2D GAB2 FSIP2 JUP PTPN13 ALMS1 MTUS1 NFATC3 STARD9 RABGAP1L SEC24B MAD1L1 WNK3 FOXO3 CRTC3 TTC28 GRIP1 VPS13D LMO7 ANKRD11 PAN3 GAB1 TP53BP2 DOP1A | 4.55e-14 | 861 | 285 | 34 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 ERBB2 MAN2A2 INTS1 NAGLU KIAA0319L IRS1 LYST KMT2C TDRD3 HEG1 PSME4 PER2 CLCN7 ZNRF3 ZMIZ2 MAD1L1 RIPOR1 HERC2 HERC1 RIC1 FOXO3 NDST1 HECTD4 CHD8 REV3L ATP13A2 NCOR1 KLF10 BTBD7 SCARB1 ANKRD11 DIP2C DEPDC5 CABIN1 SYMPK | 2.21e-12 | 1105 | 285 | 36 | 35748872 |
| Pubmed | RGPD4 GAPVD1 ZNF148 ZGRF1 ZMYM2 BCOR NEK9 JUP PTPN13 ALMS1 ZMIZ2 TNRC6A CHD6 MGA RBM11 TTC28 CHD8 ECPAS PHC1 NCOR1 TBK1 TP53BP2 | 7.21e-12 | 418 | 285 | 22 | 34709266 | |
| Pubmed | RIPOR2 DAB2 ZMYM2 MEF2D GAB2 KMT2C JUP TNRC6A CHD6 HERC2 MGA CRTC3 ANK3 KTN1 HIPK2 CHD8 RELA CREBBP ITSN2 SLC4A4 TNS1 ZHX1 GAB1 | 2.02e-11 | 486 | 285 | 23 | 20936779 | |
| Pubmed | FOXJ2 ZHX3 KLF8 ZNF148 BACH1 ZMYM2 IRF1 RXRA MEF2D STAT4 STAT5A JARID2 NFE2L1 NFE2L2 ZMIZ2 NFKB1 MGA SOX6 FOXO3 BAZ1B RELA RUNX2 PHC1 ZC3H10 NCOR1 GTF2H2 KLF10 BTBD7 KDM4A | 3.71e-11 | 808 | 285 | 29 | 20412781 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 SPTLC3 KLF8 ERBB2 MCM8 NFASC SSBP3 NEK9 RXRA ALX4 KMT2C PTPN13 UBAP2L MAD1L1 EXOC6B RIPOR1 CHD6 MAML3 RIC1 FOXO3 PRUNE2 ANK3 HECTD4 HIPK2 ECPAS SEC22A CREBBP LRCH3 GTF2H2 CMIP PLXDC2 GPR137C SCARB1 TBK1 ANKRD11 DIP2C PAN3 AADAT AFF4 DOP1A | 4.56e-11 | 1489 | 285 | 40 | 28611215 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ZHX3 DCHS2 GAPVD1 NCKAP1 BACH1 STAT5A KMT2C HERC1 TAPBP RIC1 MPP1 ANK3 KTN1 ECPAS PRPF8 VPS13D LMO7 ANKRD11 KDM4A MYOM2 ATM CDH7 | 2.00e-10 | 497 | 285 | 22 | 36774506 |
| Pubmed | RGPD4 TANC2 NCKAP1 NHSL2 ZMYM2 NFASC BCOR NEK9 TDRD3 PTPRD NFATC3 UBAP2L MAD1L1 HERC2 MGA FOXG1 WNK3 ANK3 DSCAM KTN1 HECTD4 CHD8 NCOR1 TBK1 SLC4A4 CABIN1 TNS1 NEURL4 AFF4 TP53BP2 | 4.98e-10 | 963 | 285 | 30 | 28671696 | |
| Pubmed | TANC2 SYTL2 TOGARAM1 NEK9 SHROOM4 ALMS1 MGA MAML3 RIC1 PUS7 DOCK2 PRUNE2 SH3TC2 KTN1 ATG14 VPS13D CMIP CNTNAP4 DIP2C NEURL4 DOP1A | 1.04e-09 | 493 | 285 | 21 | 15368895 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXJ2 ZHX3 KLF8 ZNF148 BACH1 IRF1 RXRA MEF2D ALX4 HSF5 STAT4 STAT5A NFATC3 NFE2L1 NFE2L2 NFKB1 TPRX1 MGA FOXG1 SOX6 FOXO3 NR4A3 RELA RUNX2 TBX18 KLF10 ASCL1 ZHX1 | 2.44e-09 | 908 | 285 | 28 | 19274049 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GAPVD1 NCKAP1 JADE3 CEP85L KIAA0319L TAB2 ALMS1 MTUS1 NFATC3 NFKB1 SEC24B TNRC6A HERC2 MGA FOXO3 TTC28 BMP2K RELA ECPAS GRIP1 NCOR1 TBK1 ITSN2 CEP41 PAN3 NEURL4 TP53BP2 | 2.75e-09 | 853 | 285 | 27 | 28718761 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DAB2 RAD54L2 NEK9 NFE2L1 NFE2L2 ZMIZ2 MGA RIC1 PRUNE2 CRTC3 ANK3 VPS37B NCOR1 CCDC87 ATM NEURL4 ZHX1 GAB1 TP53BP2 | 3.66e-09 | 430 | 285 | 19 | 35044719 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 ZGRF1 ZMYM2 TAB2 RAD54L2 BCOR TDRD3 ALMS1 NFATC3 RECQL5 TNRC6A MPP1 RBM11 TTC28 HIPK2 BAZ1B CREBBP NCOR1 IGF2BP3 LMO7 TBK1 GAB1 | 4.47e-09 | 588 | 285 | 22 | 38580884 |
| Pubmed | ZHX3 NFASC TOGARAM1 TAB2 KMT2C ALMS1 CLCN6 ZNRF3 CHD6 PRUNE2 TTC28 CHD8 LMO7 DIP2C | 6.19e-09 | 225 | 285 | 14 | 12168954 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF148 ZMYM2 SSBP2 RAD54L2 BCOR KMT2C ALMS1 ZMIZ2 TPRX1 MGA BAZ1B CHD8 CREBBP NCOR1 ASXL3 TBK1 ZHX1 | 6.43e-09 | 351 | 285 | 17 | 38297188 |
| Pubmed | GAPVD1 ZNF148 BCOR NEK9 KMT2C JUP PTPN13 ALMS1 UBAP2L SEC24B MGA ANK3 TTC28 KTN1 BAZ1B CHD8 CREBBP NCOR1 LMO7 TP53BP2 SYMPK | 6.92e-09 | 549 | 285 | 21 | 38280479 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GAPVD1 INTS1 NAGLU NFASC IRS1 KMT2C TDRD3 JUP ZFR2 CHD6 ARHGAP20 FAT4 KTN1 ARHGAP9 SH2D2A REV3L ECPAS PRPF8 IGF2BP3 TBK1 CCDC87 ATM CFAP57 SYMPK | 1.24e-08 | 736 | 285 | 24 | 29676528 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FOXJ2 BACH1 ZMYM2 IRF1 SSBP2 SSBP3 RXRA ALX4 JARID2 PER2 NFATC3 NFE2L1 NFE2L2 NFKB1 MAML3 FOXG1 SOX6 MED16 NR4A3 RELA RUNX2 CREBBP TBX18 GTF2H2 ASCL1 DIP2C | 2.06e-08 | 877 | 285 | 26 | 20211142 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 ZNF148 JADE3 INTS1 ZMYM2 BCOR DHX8 FSIP2 RECQL5 CHD6 HERC2 MGA RBM11 BAZ1B CHD8 PHC1 MASTL KDM4A CABIN1 ZHX1 AFF4 | 3.98e-08 | 608 | 285 | 21 | 36089195 |
| Pubmed | SART3 ERBB2 GAPVD1 JADE3 NFASC BCOR KMT2C PSME4 MTUS1 TNRC6A FLRT3 ARHGAP20 PDPR HECTD4 CHD8 ECPAS LMO7 DEPDC5 KDM4A | 9.83e-08 | 529 | 285 | 19 | 14621295 | |
| Pubmed | FOXJ2 ZHX3 BACH1 IRF1 RXRA MEF2D ALX4 STAT4 STAT5A KMT2C PER2 NFE2L1 ZMIZ2 NFKB1 MAML3 FOXG1 BAZ1B NR4A3 CREBBP PHC1 LMO7 KDM4A | 1.21e-07 | 709 | 285 | 22 | 22988430 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 TANC2 SART3 GAPVD1 NCKAP1 BACH1 BBS2 STYXL2 SSBP2 NEK9 GAB2 PTPN13 NFKB1 RABGAP1L SEC24B EXOC6B RIPOR1 FOXO3 CRTC3 ANK3 KTN1 PRPF8 CTSA CREBBP LRCH3 LMO7 TBK1 PAN3 ZW10 NEURL4 TP53BP2 | 1.73e-07 | 1321 | 285 | 31 | 27173435 |
| Pubmed | GAPVD1 DAB2 TDRD3 PTPN13 ALMS1 MTUS1 TNRC6A TTC28 IGF2BP3 VPS13D GAB1 TP53BP2 | 1.83e-07 | 209 | 285 | 12 | 36779422 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXJ2 SART3 GAPVD1 ZNF148 NCKAP1 ZMYM2 RXRA MEF2D ALX4 NFKB1 MAD1L1 TAF10 MGA FOXG1 FOXO3 KTN1 RELA REV3L ECPAS PRPF8 CREBBP NCOR1 CABIN1 SYMPK | 2.09e-07 | 857 | 285 | 24 | 25609649 |
| Pubmed | ZSWIM8 DCHS2 CEP85L BACH1 KIAA0319L ZMYM2 RAD54L2 CORO2B PTPN13 PTPRD NFE2L2 CHD6 HERC2 MTUS2 SOX6 NDST1 RBM11 ANK3 DSCAM TTC28 HECTD4 REV3L PRPF8 CREBBP LMO7 ASCL1 KDM4A ATM CABIN1 AFF4 | 3.08e-07 | 1285 | 285 | 30 | 35914814 | |
| Pubmed | TANC2 ZHX3 ZMYM2 TAB2 BCOR FGD5 CHD6 MAML3 FAT4 RBM11 TTC28 KTN1 MUC16 NR4A3 ATG14 REV3L CREBBP NCOR1 ASXL3 ITSN2 | 3.94e-07 | 638 | 285 | 20 | 31182584 | |
| Pubmed | A2M ERBB2 TAB2 F8 RXRA STAT5A JUP NFKB1 DOCK2 FOXO3 RELA CREBBP OSMR MAPK11 GAB1 | 5.15e-07 | 371 | 285 | 15 | 25241761 | |
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 10075655 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 19066718 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 8746784 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 26348541 | ||
| Pubmed | Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. | 5.45e-07 | 3 | 285 | 3 | 15044535 | |
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 27027438 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 22467641 | ||
| Pubmed | 5.45e-07 | 3 | 285 | 3 | 19507243 | ||
| Pubmed | NAGLU TAB2 BCOR TDRD3 PTPN13 PTPRD CLCN7 MTUS1 PTPRZ1 NFKB1 SEC24B TNRC6A RELL1 HERC2 HERC1 PDPR ANK3 RELA FAM171B NCOR1 MAPK11 TNS1 NEURL4 GAB1 TP53BP2 SYMPK | 6.58e-07 | 1049 | 285 | 26 | 27880917 | |
| Pubmed | 7.57e-07 | 157 | 285 | 10 | 30186101 | ||
| Pubmed | SART3 ZHX3 ZSWIM8 DAB2 RAD54L2 BCOR ZNRF3 UBAP2L MAD1L1 CHD6 FAT4 RBM11 BEND2 ZC3H10 NCOR1 ENTPD6 ZHX1 MEGF11 TP53BP2 | 8.10e-07 | 608 | 285 | 19 | 16713569 | |
| Pubmed | DNAJB12 SART3 NCKAP1 INTS1 ZMYM2 BCOR SSBP3 DHX8 JARID2 KMT2C TDRD3 PTPN13 RECQL5 SEC24B TNRC6A CHD6 HERC2 TAF10 TAF1L TAPBP BMP2K MED16 KTN1 BAZ1B CHD8 RELA LRCH3 IGFBP5 ITSN2 ANKRD11 ZHX1 AFF4 | 8.35e-07 | 1497 | 285 | 32 | 31527615 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SART3 ZNF148 ZMYM2 RAD54L2 BCOR MEF2D UBAP2L SEC24B MGA BAZ1B CHD8 CREBBP NCOR1 KLF10 MASTL SYMPK | 9.82e-07 | 444 | 285 | 16 | 34795231 |
| Pubmed | DCAF1 ZHX3 RIPOR2 NCKAP1 PER2 UBAP2L STARD9 ZFR2 RABGAP1L RIPOR1 CHD6 TTC28 BTBD7 ITSN2 MEGF11 | 1.63e-06 | 407 | 285 | 15 | 12693553 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 27031383 | ||
| Pubmed | MiR-138 indirectly regulates the MDR1 promoter by NF-κB/p65 silencing. | 2.16e-06 | 4 | 285 | 3 | 28153721 | |
| Pubmed | Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells. | 2.16e-06 | 4 | 285 | 3 | 38805570 | |
| Pubmed | Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. | 2.16e-06 | 4 | 285 | 3 | 21262351 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 9556555 | ||
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 15687488 | ||
| Pubmed | Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. | 2.16e-06 | 4 | 285 | 3 | 11739381 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | TAGAP KMT2C PTPN13 PTPRD SOX6 SH3TC2 DSCAM SH2D2A FIGN ZC3H10 KLF10 TNS1 | 2.25e-06 | 265 | 285 | 12 | 19240061 |
| Pubmed | ZHX3 ZNF148 ZMYM2 SSBP2 BCOR MEF2D MGA MED16 CHD8 CREBBP NCOR1 AFF4 | 2.53e-06 | 268 | 285 | 12 | 33640491 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | ERBB2 ZNF148 KIAA0319L DAB2 RAD54L2 BCOR JUP TNRC6A CRTC3 NCOR1 | 2.62e-06 | 180 | 285 | 10 | 35198878 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.56e-06 | 146 | 285 | 9 | 23892456 | |
| Pubmed | GAPVD1 RIPOR2 TAGAP TAB2 BCOR KMT2C JUP PTPN13 PSME4 UBAP2L NFE2L1 HERC1 MGA TAPBP ANK3 BMP2K HIPK2 BAZ1B FAM171B ENTPD6 IRAK4 MASTL PAN3 TNS1 AFF4 | 3.88e-06 | 1084 | 285 | 25 | 11544199 | |
| Pubmed | ZNF148 NEK9 MEF2D KMT2C ALMS1 UBAP2L NFE2L2 STARD9 GARIN5B NCOR1 NEURL4 | 4.01e-06 | 233 | 285 | 11 | 37704626 | |
| Pubmed | ZHX3 ERBB2 MCM8 CYP2J2 TRPC6 ZMYM2 BBS2 ADGRL4 TC2N PTPRZ1 STARD9 RABGAP1L KTN1 C2orf78 SEC22A LRCH3 RASSF6 CEP41 GAB1 | 4.69e-06 | 686 | 285 | 19 | 29987050 | |
| Pubmed | TANC2 GAPVD1 NCKAP1 PTPN13 ALMS1 TNRC6A FOXO3 CRTC3 TTC28 ECPAS LRCH3 GRIP1 LMO7 TBK1 TP53BP2 | 4.96e-06 | 446 | 285 | 15 | 24255178 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 12700228 | ||
| Pubmed | CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. | 5.38e-06 | 5 | 285 | 3 | 17932106 | |
| Pubmed | Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis. | 5.38e-06 | 5 | 285 | 3 | 22435562 | |
| Pubmed | Structural insights into the functions of TBK1 in innate antimicrobial immunity. | 5.38e-06 | 5 | 285 | 3 | 23746807 | |
| Pubmed | The structure and interactions of the proline-rich domain of ASPP2. | 5.38e-06 | 5 | 285 | 3 | 18448430 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 14568984 | ||
| Pubmed | Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. | 5.38e-06 | 5 | 285 | 3 | 18316612 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 15871905 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 11160671 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 9659924 | ||
| Pubmed | The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. | 5.38e-06 | 5 | 285 | 3 | 11931769 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 17434128 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TANC2 ZSWIM8 GAPVD1 MCM8 JADE3 BACH1 DAB2 TAB2 NEK9 MEF2D GAB2 UBAP2L NFKB1 SEC24B RIPOR1 FOXO3 CRTC3 BMP2K RELA VPS37B BTBD7 TBK1 CEP41 PAN3 | 5.85e-06 | 1038 | 285 | 24 | 26673895 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | GAPVD1 NCKAP1 JADE3 STK17A INTS1 LYST NEK9 TAF10 TAF1L BMP2K MED16 DDR2 HIPK2 CREBBP GTF2H2 RASSF6 TBK1 IRAK4 SLC4A4 MAPK11 TNS1 AFF4 | 7.27e-06 | 910 | 285 | 22 | 36736316 |
| Pubmed | FOXJ2 ZHX3 RXRA GFRA2 JARID2 PTPRD PTPRZ1 FLRT3 SOX6 FOXO3 ASCL1 | 8.13e-06 | 251 | 285 | 11 | 29031500 | |
| Pubmed | A2M SYTL2 DAB2 ZMYM2 RXRA JUP CHD6 HERC2 HERC1 MGA ANK3 ARHGAP9 CREBBP GRIP1 NCOR1 KLF10 TP53BP2 | 9.19e-06 | 591 | 285 | 17 | 15231748 | |
| Pubmed | Dengue hemorrhagic fever is associated with polymorphisms in JAK1. | 1.04e-05 | 91 | 285 | 7 | 20588308 | |
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 17189385 | ||
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 14560022 | ||
| Pubmed | NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. | 1.07e-05 | 6 | 285 | 3 | 10498867 | |
| Pubmed | The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. | 1.07e-05 | 6 | 285 | 3 | 10357819 | |
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 22528837 | ||
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 17312272 | ||
| Pubmed | FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. | 1.07e-05 | 6 | 285 | 3 | 22893124 | |
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 22658979 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 ZHX3 GAPVD1 ZNF148 ZMYM2 BCOR NEK9 TDRD3 JUP PTPN13 ALMS1 UBAP2L SEC24B PUS7 RBM11 KTN1 BAZ1B PRPF8 IGF2BP3 MASTL AFF4 TP53BP2 | 1.09e-05 | 934 | 285 | 22 | 33916271 |
| Pubmed | Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. | 1.23e-05 | 18 | 285 | 4 | 15829968 | |
| Pubmed | 1.26e-05 | 263 | 285 | 11 | 20932939 | ||
| Pubmed | 1.55e-05 | 19 | 285 | 4 | 32075740 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | JADE3 TAB2 ALMS1 UBAP2L SEC24B TNRC6A MPP1 BMP2K GTF2H2 TBK1 IRAK4 TP53BP2 | 1.62e-05 | 322 | 285 | 12 | 39098523 |
| Pubmed | RIPOR2 INTS1 KMT2C PTPN13 PTPRD PSME4 UBAP2L BAZ1B CMIP ASCL1 SLC4A4 CDH4 | 1.62e-05 | 322 | 285 | 12 | 26514267 | |
| Pubmed | RNA-destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling. | 1.86e-05 | 7 | 285 | 3 | 19738286 | |
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 16059920 | ||
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 28930658 | ||
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 18241676 | ||
| Pubmed | LRP16 integrates into NF-κB transcriptional complex and is required for its functional activation. | 1.86e-05 | 7 | 285 | 3 | 21483817 | |
| Pubmed | Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. | 1.86e-05 | 7 | 285 | 3 | 19843958 | |
| Pubmed | DCAF1 TANC2 ZSWIM8 ERBB2 ZNF148 MCM8 ABCA12 BCOR TC2N ALMS1 ZNRF3 MTUS1 TNRC6A TAF10 MGA TTC28 FAT3 BAZ1B CHD8 REV3L CREBBP TBK1 OSMR AFF4 | 1.92e-05 | 1116 | 285 | 24 | 31753913 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FOXJ2 DCAF1 DNAJB12 GAPVD1 NCKAP1 INTS1 ZMYM2 NFASC TAB2 IRS1 JUP MGA HSDL1 FOXG1 BMP2K MED16 KTN1 DDR2 BAZ1B NR4A3 CHD8 PRPF8 SEC22A SCARB1 SYMPK | 2.26e-05 | 1203 | 285 | 25 | 29180619 |
| Pubmed | 2.49e-05 | 104 | 285 | 7 | 9205841 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 GAPVD1 ZNF148 JADE3 BACH1 DAB2 ZMYM2 BCOR MEF2D UBAP2L MAD1L1 RIPOR1 BAZ1B ECPAS NCOR1 LMO7 ATM ZHX1 SYMPK | 2.51e-05 | 774 | 285 | 19 | 15302935 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ERBB2 ZNF148 INTS1 NEK9 CLCN7 ZNRF3 NFE2L2 RABGAP1L FLRT3 RELL1 HERC1 PDPR PCDHAC2 CHD8 CMIP LMO7 SCARB1 ENTPD6 ATM OSMR ZW10 SLC4A4 SYMPK | 2.54e-05 | 1061 | 285 | 23 | 33845483 |
| Pubmed | GAPVD1 KIAA0319L GAB2 PTPN13 SEC24B TNRC6A RELL1 MGA FAT4 ANK3 DSCAM TTC28 BMP2K MUC16 RELA FAM171B NCOR1 IGF2BP3 GAB1 | 2.65e-05 | 777 | 285 | 19 | 35844135 | |
| Interaction | HDAC1 interactions | DCAF1 ZHX3 C2orf69 GAPVD1 ZNF148 ZGRF1 BACH1 ZMYM2 TAB2 BCOR NEK9 MEF2D STAT5A JUP PTPN13 ALMS1 NFE2L2 ZMIZ2 NFKB1 MAD1L1 TNRC6A MGA FOXG1 SOX6 RBM11 TTC28 CHD8 RELA RUNX2 ECPAS CREBBP LRCH3 GRIP1 NCOR1 LMO7 TBK1 KDM4A ATM MAPK11 CABIN1 ZHX1 TP53BP2 SYMPK | 4.79e-10 | 1108 | 274 | 43 | int:HDAC1 |
| Interaction | PHF21A interactions | KLF8 GAPVD1 ZGRF1 ZMYM2 BCOR NEK9 PTPN13 ALMS1 ZMIZ2 RABGAP1L TNRC6A CHD6 TAF10 MGA RBM11 TTC28 CHD8 ECPAS TBK1 TP53BP2 | 5.47e-08 | 343 | 274 | 20 | int:PHF21A |
| Interaction | HDAC3 interactions | DCAF1 ZNF148 ZMYM2 TAB2 BCOR RXRA MEF2D NFE2L2 NFKB1 SOX6 RELA RUNX2 PPAT CREBBP NCOR1 ANKRD11 KDM4A MAPK11 | 3.16e-07 | 313 | 274 | 18 | int:HDAC3 |
| Interaction | AR interactions | SART3 ZHX3 ZNF148 ZMYM2 TAB2 SSBP2 RAD54L2 BCOR NEK9 MEF2D KMT2C JUP UBAP2L ZMIZ2 NFKB1 MGA FOXG1 MED16 HECTD4 HIPK2 CHD8 RELA SH2D2A RUNX2 ECPAS PRPF8 CREBBP GRIP1 NCOR1 GTF2H2 KDM4A TNS1 AFF4 SYMPK | 7.05e-07 | 992 | 274 | 34 | int:AR |
| Interaction | FBXO22 interactions | ZHX3 DCHS2 GAPVD1 NCKAP1 BACH1 STAT5A KMT2C HERC1 TAPBP RIC1 MPP1 ANK3 KTN1 ECPAS PRPF8 NCOR1 VPS13D LMO7 ANKRD11 KDM4A MYOM2 ATM CDH7 | 1.49e-06 | 540 | 274 | 23 | int:FBXO22 |
| Interaction | TOP3B interactions | TANC2 ERBB2 MAN2A2 INTS1 NAGLU KIAA0319L IRS1 LYST KMT2C TDRD3 HEG1 PSME4 PER2 CLCN7 ZNRF3 UBAP2L ZMIZ2 RECQL5 SEC24B MAD1L1 RIPOR1 HERC2 HERC1 RIC1 FOXO3 NDST1 RBM11 KTN1 HECTD4 CHD8 REV3L ATP13A2 NCOR1 KLF10 RMDN1 BTBD7 SCARB1 ANKRD11 DIP2C DEPDC5 KDM4A CABIN1 SYMPK | 1.52e-06 | 1470 | 274 | 43 | int:TOP3B |
| Interaction | ERG interactions | ZNF148 ZMYM2 RAD54L2 BCOR MEF2D KMT2C PTPRD HERC2 SOX6 HIPK2 PRPF8 CREBBP NCOR1 IGFBP5 | 2.39e-06 | 223 | 274 | 14 | int:ERG |
| Interaction | SOCS3 interactions | 2.60e-06 | 110 | 274 | 10 | int:SOCS3 | |
| Interaction | YWHAH interactions | TANC2 GAPVD1 NCKAP1 CEP85L NHSL2 TAB2 IRS1 LYST MEF2D GAB2 JUP PTPN13 ALMS1 MTUS1 NFATC3 STARD9 RABGAP1L SEC24B MAD1L1 HERC1 WNK3 FOXO3 CRTC3 TTC28 HECTD4 CREBBP GRIP1 VPS13D LMO7 TBK1 ANKRD11 PAN3 GAB1 TP53BP2 DOP1A | 2.70e-06 | 1102 | 274 | 35 | int:YWHAH |
| Interaction | NLK interactions | 4.80e-06 | 70 | 274 | 8 | int:NLK | |
| Interaction | VDR interactions | RXRA NFKB1 FOXO3 MED16 RELA CREBBP GRIP1 NCOR1 PLXDC2 ANKRD11 | 9.47e-06 | 127 | 274 | 10 | int:VDR |
| Interaction | MAFK interactions | 9.76e-06 | 37 | 274 | 6 | int:MAFK | |
| Interaction | IRF1 interactions | 1.72e-05 | 83 | 274 | 8 | int:IRF1 | |
| Interaction | C2CD4B interactions | 2.74e-05 | 44 | 274 | 6 | int:C2CD4B | |
| Interaction | KDM1A interactions | GAPVD1 ZNF148 ZGRF1 ZMYM2 BCOR NEK9 MEF2D JUP PTPN13 ALMS1 NFE2L2 RABGAP1L TNRC6A CHD6 MGA FOXG1 SOX6 RBM11 TTC28 CHD8 RELA ECPAS VPS37B PHC1 NCOR1 TBK1 ITSN2 TP53BP2 SYMPK | 3.58e-05 | 941 | 274 | 29 | int:KDM1A |
| Interaction | IRF9 interactions | 4.02e-05 | 47 | 274 | 6 | int:IRF9 | |
| Interaction | ZHX2 interactions | 4.18e-05 | 69 | 274 | 7 | int:ZHX2 | |
| Interaction | GSK3B interactions | GAPVD1 NCKAP1 DAB2 IRF1 TAB2 IRS1 RXRA TDRD3 PTPN13 ALMS1 MTUS1 NFE2L1 NFE2L2 NFKB1 TNRC6A CHD6 HERC2 MPP1 TTC28 RELA IGF2BP3 VPS13D TBK1 ENTPD6 ZHX1 GAB1 TP53BP2 | 5.76e-05 | 868 | 274 | 27 | int:GSK3B |
| Interaction | KLF5 interactions | ZNF148 BCOR RXRA MEF2D KMT2C JUP NFKB1 MGA RBM11 CREBBP NCOR1 | 7.71e-05 | 195 | 274 | 11 | int:KLF5 |
| Interaction | LHX4 interactions | 9.47e-05 | 166 | 274 | 10 | int:LHX4 | |
| GeneFamily | Fibronectin type III domain containing | 3.41e-05 | 160 | 181 | 9 | 555 | |
| GeneFamily | Cadherin related | 6.05e-04 | 17 | 181 | 3 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.21e-04 | 18 | 181 | 3 | 91 | |
| GeneFamily | Ankyrin repeat domain containing|NF-kappa B complex subunits | 9.77e-04 | 5 | 181 | 2 | 1254 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.13e-03 | 206 | 181 | 8 | 682 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SART3 GAPVD1 ZNF148 BACH1 TOGARAM1 IRS1 SSBP2 JARID2 HEG1 PER2 MTUS1 NFE2L2 NFKB1 RABGAP1L FOXO3 BAZ1B REV3L CREBBP IGF2BP3 DOP1A | 9.83e-11 | 300 | 280 | 20 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 GAPVD1 ZNF148 NCKAP1 TRPC1 ZMYM2 TOGARAM1 TAB2 IRS1 SSBP2 JARID2 TDRD3 HEG1 PTPN13 PSME4 NFATC3 NFKB1 RABGAP1L SEC24B MAD1L1 FOXO3 TTC28 BMP2K DDR2 BAZ1B REV3L CREBBP IGF2BP3 KLF10 ITSN2 OSMR TP53BP2 | 8.92e-10 | 856 | 280 | 32 | M4500 |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | TANC2 RIPOR2 SYTL2 TC2N RABGAP1L HERC1 MPPE1 FOXO3 CRTC3 HECTD4 ATG14 RASSF6 ATM PAN3 | 2.66e-08 | 195 | 280 | 14 | M7397 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | GAPVD1 RIPOR2 MAN2A2 ZNF148 TAGAP CEP85L STK17A IRF1 TAB2 LYST NEK9 MEF2D STAT4 STAT5A ABCB1 JARID2 KMT2C HEG1 TC2N NFATC3 RABGAP1L HERC1 TAPBP DOCK2 KTN1 ICAM3 HECTD4 BAZ1B ARHGAP9 SH2D2A REV3L RUNX2 PRPF8 CREBBP NCOR1 TBK1 ITSN2 IRAK4 ANKRD11 GAB3 ATM | 2.74e-08 | 1492 | 280 | 41 | M40023 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | TOGARAM1 IRS1 SSBP2 JARID2 MTUS1 NFKB1 RABGAP1L FOXO3 REV3L IGF2BP3 DOP1A | 4.85e-07 | 145 | 280 | 11 | M1810 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | A2M SSBP2 PTPRD HERC1 MAML3 TTC28 HIPK2 IGFBP5 PLXDC2 LMO7 ANKRD11 TNS1 | 4.93e-07 | 177 | 280 | 12 | M39245 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | BACH1 NFASC SSBP2 PTPN13 PTPRD ZNRF3 RABGAP1L MAML3 SOX6 PLXDC2 ANKRD11 PAN3 ARMH4 | 5.20e-07 | 212 | 280 | 13 | M39221 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RIPOR2 CEP85L TRPC1 IRS1 SSBP2 LYST GAB2 ADGRL4 ABCB1 JARID2 KMT2C PER2 MTUS1 RABGAP1L RIPOR1 FGD5 ECPAS CREBBP NCOR1 PLXDC2 LMO7 RMDN1 ITSN2 MYOM2 OSMR ZHX1 SHISA3 | 5.71e-07 | 854 | 280 | 27 | M1533 |
| Coexpression | NATSUME_RESPONSE_TO_INTERFERON_BETA_UP | 8.17e-07 | 70 | 280 | 8 | M6897 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | ZHX3 PTPRD RABGAP1L TNRC6A PRUNE2 ANK3 TTC28 SLC13A3 PLXDC2 ANKRD11 DIP2C SLC4A4 TNS1 | 8.33e-07 | 221 | 280 | 13 | M39222 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RIPOR2 CEP85L TRPC1 IRS1 SSBP2 LYST GAB2 ADGRL4 ABCB1 JARID2 KMT2C PER2 MTUS1 RABGAP1L RIPOR1 FGD5 ECPAS CREBBP NCOR1 PLXDC2 LMO7 RMDN1 ITSN2 MYOM2 OSMR ZHX1 SHISA3 | 1.20e-06 | 888 | 280 | 27 | MM1018 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | TANC2 DOK6 ZHX3 BCOR SHROOM4 NFE2L1 TNRC6A CHD6 PRUNE2 BAZ1B SLC13A3 CREBBP NCOR1 NSUN6 ANKRD11 SLC4A4 TNS1 | 2.93e-06 | 417 | 280 | 17 | M39224 |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | MAN2A2 TRPC1 SSBP3 LYST MEF2D CORO2B PER2 NFATC3 HERC1 FOXO3 HIPK2 VPS37B BTBD7 ANKRD11 | 3.83e-06 | 294 | 280 | 14 | M41112 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | ZHX3 KMT2C CORO2B HERC1 RIC1 BAZ1B PRPF8 CREBBP NCOR1 DEPDC5 ATM | 4.07e-06 | 180 | 280 | 11 | M8239 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | FOXJ2 C2orf69 RIPOR2 MAN2A2 MCM8 INTS1 KIAA0319L IRF1 RAD54L2 MEF2D GAB2 JARID2 CLCN6 CLCN7 ZMIZ2 RIPOR1 NBPF3 DOCK2 PDPR MED16 CREBBP CMIP KLF10 ENTPD6 NBPF10 ANKRD11 | 5.31e-06 | 905 | 280 | 26 | M40865 |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 | 8.27e-06 | 125 | 280 | 9 | M5888 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | TANC2 ZNF148 BACH1 MS4A7 CREBBP BTBD7 NBPF10 ATM PAN3 AFF4 SYMPK | 8.32e-06 | 194 | 280 | 11 | M7306 |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 | 9.41e-06 | 127 | 280 | 9 | MM1113 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | ERBB2 INTS1 IRF1 SSBP3 RXRA JUP CLCN7 UBAP2L MED16 CHD8 VPS37B | 1.11e-05 | 200 | 280 | 11 | M7256 |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | MAN2A2 TRPC6 SFR1 CHD6 SOX6 FOXO3 HECTD4 PHC1 PLXDC2 DIP2C GAB1 | 1.11e-05 | 200 | 280 | 11 | M7495 |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | LYST GAB2 ZNRF3 NFKB1 RABGAP1L BMP2K HIPK2 NR4A3 REV3L VPS37B TP53BP2 | 1.11e-05 | 200 | 280 | 11 | M6943 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TANC2 ZHX3 C2orf69 MAN2A2 NCKAP1 BBS2 NFASC TOGARAM1 TAB2 LRRTM3 LYST KMT2C NFE2L1 EDARADD MTUS2 MPP1 PRUNE2 KTN1 HECTD4 ECPAS PRPF8 KLF10 RASSF6 DIP2C TNS1 AFF4 | 1.16e-05 | 946 | 280 | 26 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | TANC2 PDK4 BACH1 MTUS1 NFE2L2 HERC1 MAML3 ANK3 GRIP1 IGFBP5 GAB1 AFF4 | 1.16e-05 | 240 | 280 | 12 | M39236 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.73e-05 | 137 | 280 | 9 | M39241 | |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 2.00e-05 | 175 | 280 | 10 | M2940 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | DNAJB12 PDK4 BACH1 TOGARAM1 SSBP2 PTPN13 NFE2L2 RABGAP1L SEC24B MPPE1 DOCK2 NDST1 KTN1 GRB14 REV3L RUNX2 CREBBP IGFBP5 ITSN2 KDM4A TP53BP2 | 2.60e-05 | 705 | 280 | 21 | M1410 |
| Coexpression | SCHEIDEREIT_IKK_TARGETS | 3.47e-05 | 18 | 280 | 4 | M17115 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN | 3.86e-05 | 36 | 280 | 5 | M13327 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | SYTL2 PSME4 CHD6 HERC1 HECTD4 NR4A3 ATG14 VPS13D NBPF10 ZHX1 | 3.87e-05 | 189 | 280 | 10 | M8275 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | DOK6 RIPOR2 SYTL2 NFASC SSBP3 HERC1 USH2A MTUS2 ANK3 DSCAM GRIP1 CMIP GPR137C ASXL3 CDH4 ZHX1 | 4.56e-05 | 465 | 280 | 16 | M39066 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX3 GAPVD1 ZNF148 ZMYM2 TAB2 IRS1 JARID2 HEG1 SEC24B FOXO3 REV3L CREBBP IGF2BP3 KLF10 ITSN2 TP53BP2 | 4.68e-05 | 466 | 280 | 16 | M13522 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 5.05e-05 | 195 | 280 | 10 | M1110 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 5.27e-05 | 196 | 280 | 10 | M3243 | |
| Coexpression | GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP | DCHS2 RIPOR2 STK17A MPP1 DNHD1 TTC28 SCARB1 CEP41 ATM NEURL4 | 5.27e-05 | 196 | 280 | 10 | M3106 |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP | 5.74e-05 | 198 | 280 | 10 | M5011 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | SART3 ZSWIM8 DAB2 LYST JARID2 HEG1 PSME4 HIPK2 SH2D2A VPS37B | 5.74e-05 | 198 | 280 | 10 | M4415 |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | 5.74e-05 | 198 | 280 | 10 | M3104 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | FOXJ2 RIPOR2 MCM8 INTS1 RAD54L2 MEF2D JARID2 CLCN6 CLCN7 ZMIZ2 NBPF3 HECTD4 ARHGAP9 CREBBP LRCH3 CMIP KLF10 NBPF10 ANKRD11 | 5.85e-05 | 634 | 280 | 19 | M40866 |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 5.98e-05 | 199 | 280 | 10 | M7259 | |
| Coexpression | GSE40443_INDUCED_VS_TOTAL_TREG_UP | TANC2 SYTL2 BACH1 BCOR JARID2 EDARADD NR4A3 SH2D2A PHC1 PLXDC2 | 5.98e-05 | 199 | 280 | 10 | M9198 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 DOK6 RIPOR2 CEP85L SYTL2 NFASC SSBP3 LYST FSIP2 MTUS1 RABGAP1L TNRC6A HERC1 MTUS2 WNK3 ANK3 DSCAM REV3L FAM171B GRIP1 CMIP GPR137C ASXL3 CNTNAP4 CDH4 DOP1A ARMH4 | 6.11e-05 | 1106 | 280 | 27 | M39071 |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | ZSWIM8 MAN2A2 ABCB1 ALMS1 PER2 MTUS1 SEC24B CREBBP KLF10 MYOM2 | 6.24e-05 | 200 | 280 | 10 | M8030 |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN | 6.24e-05 | 200 | 280 | 10 | M3579 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | ZSWIM8 RIPOR2 BACH1 SFR1 RELL1 FAM171B VPS37B KLF10 AFF4 TP53BP2 | 6.24e-05 | 200 | 280 | 10 | M9925 |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP | RIPOR1 TAPBP MPP1 HIPK2 RELA SH2D2A ATP13A2 VPS37B COMMD3 VPS13D | 6.24e-05 | 200 | 280 | 10 | M6035 |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | ZHX3 ERBB2 STK17A NFASC TDRD3 PTPRD ALMS1 PER2 FOXO3 PRUNE2 DDR2 SLC13A3 IGFBP5 LMO7 OSMR MAPK11 | 6.96e-05 | 482 | 280 | 16 | M12144 |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | A2M GFRA2 STAT4 JARID2 PTPN13 NFATC3 FLRT3 SOX6 FAT4 FAT3 IGFBP5 PLXDC2 MYOM2 CDH4 SHISA3 | 8.09e-05 | 437 | 280 | 15 | M15981 |
| Coexpression | HAN_SATB1_TARGETS_DN | SPTLC3 ERBB2 SSBP2 JUP MTUS1 FOXG1 MPP1 SH3TC2 RUNX2 ECPAS VPS37B NCOR1 OSMR TNS1 | 8.26e-05 | 388 | 280 | 14 | M15491 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 8.31e-05 | 207 | 280 | 10 | MM475 | |
| Coexpression | CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN | 8.58e-05 | 168 | 280 | 9 | M45039 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | ZSWIM8 JADE3 BACH1 NAGLU SSBP2 LYST DHX8 HEG1 PTPRD PER2 CLCN7 ZFR2 ZMIZ2 MAD1L1 COL11A2 ANK3 IGFBP5 ASCL1 SCARB1 TBK1 SLC4A4 TNS1 CDH4 | 1.30e-04 | 909 | 280 | 23 | M41018 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 1.43e-04 | 141 | 280 | 8 | M39235 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | PRTG TRPC6 DAB2 IRF1 BCOR MS4A7 PER2 STARD9 BMP2K DDR2 REV3L FAM171B KLF10 CNTNAP4 | 1.51e-04 | 411 | 280 | 14 | M1351 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 1.58e-04 | 48 | 280 | 5 | M1246 | |
| Coexpression | ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP | 1.58e-04 | 26 | 280 | 4 | M18077 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.63e-04 | 269 | 280 | 11 | M41203 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | PRTG TRPC6 DAB2 IRF1 BCOR MS4A7 PER2 STARD9 BMP2K DDR2 REV3L FAM171B KLF10 CNTNAP4 | 1.71e-04 | 416 | 280 | 14 | MM1002 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 1.90e-04 | 78 | 280 | 6 | M9814 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | DNAJB12 FCRL2 RIPOR2 STK17A TRPC1 INTS1 GFRA2 ABCB1 PER2 CLCN6 DOCK2 ANK3 BMP2K ATM TREML2 | 2.01e-04 | 475 | 280 | 15 | M40979 |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN | STK17A TRPC1 SYTL2 TAB2 STAT4 ABCB1 HEG1 PSME4 MTUS1 RABGAP1L TBK1 ATM | 2.02e-04 | 323 | 280 | 12 | M12570 |
| Coexpression | ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON | 2.13e-04 | 28 | 280 | 4 | M39089 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 2.17e-04 | 190 | 280 | 9 | M8457 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TANC2 BACH1 IRF1 LYST MEF2D CNIH3 PER2 CLCN6 MTUS1 NFE2L2 SEC24B RIPOR1 FOXO3 ATG14 VPS37B CREBBP KLF10 ITSN2 KDM4A AFF4 TP53BP2 | 2.24e-04 | 822 | 280 | 21 | M6782 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN | 2.26e-04 | 191 | 280 | 9 | M4180 | |
| Coexpression | GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP | 2.28e-04 | 151 | 280 | 8 | M6498 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 2.35e-04 | 192 | 280 | 9 | M8272 | |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 2.53e-04 | 53 | 280 | 5 | M6303 | |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 2.54e-04 | 194 | 280 | 9 | M4687 | |
| Coexpression | GSE2706_2H_VS_8H_R848_STIM_DC_UP | 2.54e-04 | 194 | 280 | 9 | M4729 | |
| Coexpression | TBK1.DF_DN | BACH1 RXRA FLRT3 KTN1 HIPK2 IGF2BP3 SCARB1 TBK1 ANKRD11 KDM4A AFF4 | 2.76e-04 | 286 | 280 | 11 | M2864 |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN | 2.95e-04 | 198 | 280 | 9 | M9234 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | NCKAP1 CYP2J2 TRPC6 BACH1 DAB2 SSBP2 STAT4 ADGRL4 ABCB1 SOX6 ANK3 TTC28 KTN1 PHC1 KLF10 IGFBP5 PLXDC2 DIP2C AFF4 | 3.04e-04 | 721 | 280 | 19 | M1999 |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_UP | 3.06e-04 | 199 | 280 | 9 | M3314 | |
| Coexpression | GSE14308_TH2_VS_NATURAL_TREG_DN | 3.06e-04 | 199 | 280 | 9 | M3369 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP | 3.06e-04 | 199 | 280 | 9 | M5759 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 3.06e-04 | 199 | 280 | 9 | M5620 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN | 3.18e-04 | 200 | 280 | 9 | M8389 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_UP | 3.18e-04 | 200 | 280 | 9 | M4805 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN | 3.18e-04 | 200 | 280 | 9 | M8643 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 3.18e-04 | 200 | 280 | 9 | M9765 | |
| Coexpression | GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP | 3.18e-04 | 200 | 280 | 9 | M7147 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN | 3.18e-04 | 200 | 280 | 9 | M7469 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 3.18e-04 | 200 | 280 | 9 | M7532 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP | RIPOR2 SYTL2 ABCB1 PTPN13 ARHGAP20 HSDL1 TTC28 ARHGAP9 CREBBP | 3.18e-04 | 200 | 280 | 9 | M7430 |
| Coexpression | GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP | 3.18e-04 | 200 | 280 | 9 | M7742 | |
| Coexpression | GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP | 3.18e-04 | 200 | 280 | 9 | M7990 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP | 3.18e-04 | 200 | 280 | 9 | M4050 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP | 3.18e-04 | 200 | 280 | 9 | M4056 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 3.18e-04 | 200 | 280 | 9 | M7831 | |
| Coexpression | GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN | 3.18e-04 | 200 | 280 | 9 | M9062 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP | FOXJ2 CYP19A1 SYTL2 MSS51 HECTD4 ATP13A2 AADAT MAPK11 TREML2 | 3.18e-04 | 200 | 280 | 9 | M5711 |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP | 3.18e-04 | 200 | 280 | 9 | M9169 | |
| Coexpression | GSE7460_CD8_TCELL_VS_TREG_ACT_UP | 3.18e-04 | 200 | 280 | 9 | M5683 | |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP | 3.18e-04 | 200 | 280 | 9 | M5617 | |
| Coexpression | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP | 3.20e-04 | 31 | 280 | 4 | M816 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 3.24e-04 | 86 | 280 | 6 | M39247 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | ABCA13 BACH1 IRF1 TAB2 LYST CNIH3 JARID2 ADSS2 CLCN6 CLCN7 NFE2L1 ZMIZ2 FLRT3 TAPBP RBM11 MRAS TPGS2 REV3L RUNX2 SCARB1 TBK1 SLC4A4 ZHX1 TP53BP2 | 3.27e-04 | 1033 | 280 | 24 | M4196 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 PRTG CYP2J2 DAB2 NFASC IRS1 ALMS1 PTPRZ1 RABGAP1L COL11A2 ANK3 DSCAM HECTD4 HIPK2 GRB14 TPGS2 ECPAS ATP13A2 VPS37B NCOR1 PLXDC2 MASTL CABIN1 TNS1 GAB1 | 3.50e-04 | 1102 | 280 | 25 | M2369 |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE | KIAA0319L RXRA GAB2 JARID2 RIPOR1 MPPE1 MED16 ICAM3 RUNX2 CMIP | 3.59e-04 | 248 | 280 | 10 | M40874 |
| Coexpression | PILON_KLF1_TARGETS_UP | A2M DCAF1 DAB2 ITIH3 PTPRD PRRG3 RIC1 FOXO3 ANK3 BMP2K HIPK2 CHD8 GTF2H2 TBK1 PAN3 | 3.69e-04 | 503 | 280 | 15 | M2226 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | RIPOR2 TAGAP SYTL2 SSBP3 MEF2D STAT4 ABCB1 ZNRF3 NFATC3 MPP1 DOCK2 CRTC3 TTC28 NR4A3 SH2D2A VPS37B PLXDC2 GAB3 | 6.92e-06 | 405 | 277 | 18 | GSM605796_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3 | RIPOR2 TAGAP SYTL2 SSBP3 MEF2D STAT4 ABCB1 ZNRF3 CRTC3 TTC28 NR4A3 ARHGAP9 SH2D2A VPS37B PLXDC2 GAB3 TREML2 | 1.50e-05 | 388 | 277 | 17 | GSM605790_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | SPTLC3 ZHX3 GFRA2 STAT5A CORO2B FAT4 ANK3 TTC28 FAT3 HIPK2 BAZ1B REV3L FAM171B IGFBP5 CNTNAP4 MYOM2 ARMH4 | 2.76e-05 | 407 | 277 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 SPTLC3 LRRTM3 GFRA2 STAT5A CORO2B PTPRZ1 SEC24B FLRT3 HERC2 NDST1 FAT4 ANK3 TTC28 FAT3 HIPK2 BAZ1B REV3L FAM171B ECPAS TBX18 IGFBP5 ASCL1 ASXL3 CNTNAP4 ARMH4 | 2.83e-05 | 818 | 277 | 26 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | ZNF148 NHSL2 BACH1 SSBP2 SSBP3 HEG1 STARD9 HERC1 ARHGAP20 MGA FAT3 CHD8 CREBBP ASXL3 ANKRD11 DEPDC5 TNS1 | 3.31e-05 | 413 | 277 | 17 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | GAPVD1 RIPOR2 ZNF148 NHSL2 BACH1 SSBP2 SSBP3 KMT2C HEG1 STARD9 TNRC6A HERC1 ARHGAP20 MGA NDST1 FAT3 CHD8 FAM171B CREBBP VPS13D IGFBP5 ASXL3 ANKRD11 DEPDC5 TNS1 | 4.36e-05 | 790 | 277 | 25 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | RIPOR2 TAGAP SYTL2 SSBP3 MEF2D STAT4 ABCB1 ZNRF3 NFATC3 CRTC3 TTC28 ARHGAP9 SH2D2A VPS37B PLXDC2 GAB3 | 4.60e-05 | 382 | 277 | 16 | GSM476684_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | RIPOR2 TRPC6 IRS1 GFRA2 PTPRD ARHGAP20 FAT3 MUC16 IGF2BP3 IGFBP5 PLXDC2 ASXL3 TNS1 ARMH4 | 6.17e-05 | 310 | 277 | 14 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | TRPC6 SYTL2 IRS1 SSBP2 FLRT3 ARHGAP20 FAT3 DDR2 MUC16 IGF2BP3 IGFBP5 PLXDC2 ASXL3 ARMH4 SHISA3 | 6.97e-05 | 354 | 277 | 15 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TANC2 RIPOR2 ZGRF1 TRPC6 SYTL2 IRS1 SSBP2 LRRTM3 GFRA2 GAB2 PTPRD ARHGAP20 WNK3 SOX6 FAT3 DDR2 MUC16 REV3L IGFBP5 PLXDC2 ASXL3 SCARB1 TNS1 ARMH4 | 9.03e-05 | 777 | 277 | 24 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | ZNF148 NHSL2 BACH1 SSBP2 SSBP3 HEG1 HERC1 ARHGAP20 MGA FAT3 CHD8 CREBBP ASXL3 ANKRD11 DEPDC5 TNS1 | 9.40e-05 | 406 | 277 | 16 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | RIPOR2 NCKAP1 TAGAP SYTL2 LYST STAT4 ABCB1 PTPN13 ZNRF3 NFATC3 MPPE1 SH2D2A RUNX2 GAB3 MAPK11 | 1.04e-04 | 367 | 277 | 15 | GSM538401_500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | FOXJ2 IRS1 SSBP2 TDRD3 PTPRD ARHGAP20 FAT4 DDR2 FAM171B NCOR1 PLXDC2 ASXL3 GAB1 | 1.13e-04 | 288 | 277 | 13 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | FOXJ2 ZGRF1 IRS1 SSBP2 GFRA2 TDRD3 PTPRD FLRT3 ARHGAP20 MGA WNK3 FAT4 TTC28 DDR2 FAM171B TBX18 NCOR1 PLXDC2 ASXL3 CEP41 ANKRD11 CNTNAP4 GAB1 SHISA3 | 1.19e-04 | 791 | 277 | 24 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.26e-04 | 179 | 277 | 10 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | DCAF1 RIPOR2 NAPEPLD MCM8 ZMYM2 LRRTM3 GFRA2 HEG1 CORO2B PSME4 ALMS1 CLCN6 ZNRF3 PTPRZ1 HERC1 WNK3 SOX6 GPR19 PDPR FAT3 HIPK2 NR4A3 FAM171B PHC1 LRCH3 GRIP1 MASTL ATM CDH4 | 1.41e-04 | 1060 | 277 | 29 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#4_top-relative-expression-ranked_1000 | A2M ITIH3 CORO2B ARHGAP20 PZP FOXG1 SOX6 MPP1 FOXO3 HIPK2 TFR2 TBX18 MYOM2 AADAT SHISA3 | 1.48e-04 | 379 | 277 | 15 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.69e-04 | 151 | 277 | 9 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3 | BACH1 SSBP2 LYST MEF2D JUP NFATC3 MAD1L1 RIPOR1 HSDL1 HECTD4 SH2D2A PLXDC2 PAN3 TNS1 | 1.79e-04 | 343 | 277 | 14 | GSM399400_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | TANC2 PRTG TRPC1 LYST KMT2C ALMS1 RABGAP1L M1AP DOP1A SYNGR4 | 1.81e-04 | 187 | 277 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | PRTG GAPVD1 ZNF148 NHSL2 BACH1 SSBP2 SSBP3 HEG1 UBAP2L PTPRZ1 FLRT3 HERC1 ARHGAP20 MGA CHD8 FAM171B FIGN CREBBP TBX18 ASCL1 ASXL3 DEPDC5 KDM4A SHISA3 | 1.85e-04 | 815 | 277 | 24 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | GAPVD1 ZNF148 JADE3 BACH1 SSBP2 SSBP3 KMT2C HEG1 TC2N ALMS1 NFATC3 UBAP2L HERC1 MGA GPR19 PDPR CHD8 ECPAS M1AP GPR137C SPDYA DEPDC5 ATM | 2.31e-04 | 776 | 277 | 23 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | GAPVD1 SOX6 ANK3 HIPK2 NR4A3 ATG14 GRIP1 ZC3H10 IGFBP5 MEGF11 GAB1 ARMH4 | 2.91e-04 | 276 | 277 | 12 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 2.96e-04 | 129 | 277 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | TANC2 KLF8 TAGAP CEP85L LRRTM3 RAD54L2 F8 TDRD3 NFE2L2 STARD9 ARHGAP20 MAML3 WNK3 PUS7 SH3TC2 CRTC3 FAT4 MRAS MUC16 GRB14 ATG14 REV3L IGFBP5 | 3.03e-04 | 791 | 277 | 23 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_1000 | CEP85L DAB2 F8 MEF2D ADGRL4 SHROOM4 JUP HEG1 CORO2B MTUS1 NFE2L2 STARD9 RIPOR1 FGD5 HIPK2 VPS13D CMIP KLF10 IGFBP5 LMO7 ITSN2 OSMR MAPK11 TNS1 | 3.55e-04 | 852 | 277 | 24 | gudmap_kidney_adult_GlomCapSys_Tie2_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | GAPVD1 ZNF148 NHSL2 BACH1 DAB2 SSBP2 SSBP3 KMT2C HEG1 STARD9 TNRC6A HERC1 ARHGAP20 MGA NDST1 PDPR FAT3 CHD8 CREBBP ASXL3 ANKRD11 DEPDC5 TNS1 | 3.61e-04 | 801 | 277 | 23 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | NAPEPLD SSBP2 FAT4 DDR2 RUNX2 NCOR1 IGFBP5 PLXDC2 MYOM2 OSMR | 3.92e-04 | 206 | 277 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | FOXJ2 CORO2B PTPRD ALMS1 MTUS1 PTPRZ1 STARD9 EDARADD CHD6 SOX6 FAT4 FAT3 KTN1 HECTD4 CHD8 FAM171B GRIP1 GPR137C CDH4 DOP1A | 3.98e-04 | 654 | 277 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | TRPC6 SYTL2 IRS1 ARHGAP20 FAT3 MUC16 IGF2BP3 IGFBP5 ASXL3 SHISA3 | 4.08e-04 | 207 | 277 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_500 | 4.53e-04 | 28 | 277 | 4 | gudmap_developingGonad_e12.5_testes_k3_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#1_top-relative-expression-ranked_500 | 4.78e-04 | 50 | 277 | 5 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | RIPOR2 TAGAP TRPC6 IRS1 GFRA2 PTPRD STARD9 ARHGAP20 WNK3 SOX6 MRAS FAT3 MUC16 GRB14 REV3L IGF2BP3 IGFBP5 PLXDC2 ASXL3 SCARB1 TNS1 ARMH4 | 5.00e-04 | 768 | 277 | 22 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | RIPOR2 TOGARAM1 STAT4 ABCB1 KMT2C ZNRF3 HERC1 TTC28 SH2D2A REV3L ATM TREML2 DOP1A | 5.03e-04 | 336 | 277 | 13 | GSM538413_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | DCAF1 NAPEPLD MCM8 CEP85L ZGRF1 ZMYM2 GFRA2 DHX8 JARID2 TDRD3 HEG1 CORO2B PSME4 ALMS1 PTPRZ1 MAD1L1 WNK3 SOX6 KTN1 HIPK2 BAZ1B TPGS2 REV3L FAM171B PHC1 LRCH3 IGF2BP3 GTF2H2 MASTL ATM MAPK11 | 5.05e-04 | 1257 | 277 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ERBB2 TAGAP TRPC6 SYTL2 IRS1 RAD54L2 TDRD3 PTPN13 PTPRD FLRT3 ARHGAP20 WNK3 SOX6 MRAS FAT3 MUC16 REV3L IGF2BP3 IGFBP5 ASXL3 CEP41 MASTL SHISA3 | 5.61e-04 | 827 | 277 | 23 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | CYP2J2 BACH1 IRF1 SSBP2 LRRTM3 GFRA2 TDRD3 PTPRZ1 FLRT3 FAT4 DDR2 HIPK2 NR4A3 FAM171B FIGN TBX18 NCOR1 LMO7 ASCL1 ASXL3 CNTNAP4 MEGF11 ARMH4 | 5.61e-04 | 827 | 277 | 23 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SART3 PRTG ZMYM2 RXRA HEG1 CORO2B ALMS1 PTPRZ1 MAML3 FOXG1 SOX6 FAT3 KTN1 BAZ1B NR4A3 REV3L PPAT GRIP1 NCOR1 IGF2BP3 GPR137C ASCL1 CDH4 CDH7 JHY SHISA3 | 5.75e-04 | 989 | 277 | 26 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | RIPOR2 TAGAP SSBP2 SSBP3 STAT4 ABCB1 ZNRF3 NFATC3 MPP1 TTC28 SH2D2A PLXDC2 GAB3 TREML2 | 5.87e-04 | 386 | 277 | 14 | GSM605787_500 |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | A2M TANC2 DOK6 NEK10 SYTL2 BBS2 STAT4 TC2N STARD9 PZP IMPG2 ANK3 TFR2 ATM SLC4A4 | 2.60e-12 | 197 | 282 | 15 | e4331969bd911d1ebb5453f40a7057297b5389b4 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | PTPRD RABGAP1L TNRC6A EXOC6B SOX6 ANK3 TTC28 SLC13A3 CMIP PLXDC2 ANKRD11 DIP2C PAN3 SLC4A4 | 2.52e-11 | 192 | 282 | 14 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA13 ABCA12 PTPRD USH2A FAT4 FAT3 FIGN ASXL3 CNTNAP4 MYOM2 SLC4A4 | 2.44e-09 | 184 | 282 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA13 ABCA12 PTPRD USH2A FAT4 FAT3 FIGN ASXL3 CNTNAP4 MYOM2 SLC4A4 | 2.44e-09 | 184 | 282 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA13 ABCA12 PTPRD USH2A FAT4 FAT3 FIGN ASXL3 CNTNAP4 MYOM2 SLC4A4 | 2.44e-09 | 184 | 282 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | DOK6 SPTLC3 JARID2 ZNRF3 NFATC3 EDARADD EXOC6B MAML3 SOX6 TTC28 HECTD4 CMIP | 2.76e-09 | 186 | 282 | 12 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | DOK6 SPTLC3 JARID2 ZNRF3 NFATC3 EDARADD EXOC6B MAML3 SOX6 TTC28 HECTD4 CMIP | 2.76e-09 | 186 | 282 | 12 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | NCKAP1 TRPC6 JUP PTPN13 PTPRZ1 FLRT3 ANK3 GRIP1 LMO7 RASSF6 OSMR SLC4A4 | 3.51e-09 | 190 | 282 | 12 | ea19e9ce954f2dfde97388db9695325cd92ab88f |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | TANC2 GAB2 JARID2 KMT2C RABGAP1L MAML3 FOXO3 CMIP PLXDC2 ANKRD11 PAN3 ARMH4 | 4.18e-09 | 193 | 282 | 12 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | TANC2 GAB2 PTPN13 PTPRD RABGAP1L EXOC6B MAML3 ANK3 TTC28 DIP2C PAN3 GAB1 | 5.58e-09 | 198 | 282 | 12 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | SSBP2 KMT2C RABGAP1L TNRC6A EXOC6B HERC1 MAML3 ANK3 TTC28 GRIP1 DIP2C PAN3 | 5.91e-09 | 199 | 282 | 12 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-08 | 179 | 282 | 11 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SHROOM4 PTPN13 PTPRD TC2N ZNRF3 MTUS1 SOX6 ANK3 GRB14 SLC4A4 MEGF11 | 4.11e-08 | 191 | 282 | 11 | 34cc997e4e5c727495f321e6807a84aa124da486 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | A2M SYTL2 SSBP3 ADGRG4 STAT4 ABCB1 TC2N PZP SH2D2A GAB3 MYOM2 | 4.34e-08 | 192 | 282 | 11 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | A2M SYTL2 SSBP3 ADGRG4 STAT4 ABCB1 TC2N PZP SH2D2A GAB3 MYOM2 | 4.34e-08 | 192 | 282 | 11 | 58a7829b411b02b422ef75e2277a868969cc23e8 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | PTPN13 ZNRF3 SOX6 PRUNE2 ANK3 GRB14 SLC13A3 GRIP1 LMO7 DIP2C SLC4A4 | 4.57e-08 | 193 | 282 | 11 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | BACH1 SSBP2 LYST KMT2C JUP NFATC3 MAD1L1 RIPOR1 HECTD4 PLXDC2 PAN3 | 4.57e-08 | 193 | 282 | 11 | a6a864644e1b80b7417ea0a27281e79068a3fd3d |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 SPTLC3 PDK4 SYTL2 PTPN13 ZNRF3 SOX6 PRUNE2 ANK3 GRIP1 LMO7 | 5.64e-08 | 197 | 282 | 11 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CYP2J2 PTPN13 PTPRD TC2N MTUS1 PTPRZ1 ANK3 RUNX2 GRIP1 LMO7 SLC4A4 | 5.94e-08 | 198 | 282 | 11 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | ABCA13 JUP TC2N PER2 PTPRZ1 NFE2L2 ANK3 MUC16 IGFBP5 LMO7 RASSF6 | 6.25e-08 | 199 | 282 | 11 | ef5d8917c8d011184830a0b8197afc6266707b37 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-07 | 180 | 282 | 10 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 181 | 282 | 10 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 181 | 282 | 10 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.65e-07 | 182 | 282 | 10 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.65e-07 | 182 | 282 | 10 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | (4)_B_cells-(4)_B_mantle|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.78e-07 | 183 | 282 | 10 | 21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 3.08e-07 | 185 | 282 | 10 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-07 | 186 | 282 | 10 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-07 | 187 | 282 | 10 | f1ba41f2ec703251a81c46e08d45e70210f298e7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 SPTLC3 ZHX3 RIPOR2 ABCA13 ZNRF3 PRUNE2 HIPK2 DIP2C TNS1 | 3.40e-07 | 187 | 282 | 10 | c31130fc2f9f882944b2ba366a034a03f051c4b9 |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TAGAP STK17A SYTL2 IRF1 LYST STAT4 ABCB1 ARHGAP9 SH2D2A VPS37B | 3.57e-07 | 188 | 282 | 10 | 6686dbba990066568aa7573e70a7db8b4758f457 |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | RIPOR2 TAGAP STK17A SYTL2 IRF1 LYST STAT4 ABCB1 ARHGAP9 SH2D2A | 3.75e-07 | 189 | 282 | 10 | c604da558c9f4055fb36218452463539f2a73223 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-07 | 190 | 282 | 10 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZNF148 TAB2 PSME4 NFE2L2 ARHGAP20 BMP2K NCOR1 CMIP ANKRD11 SLC4A4 | 4.13e-07 | 191 | 282 | 10 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZNF148 TAB2 PSME4 NFE2L2 ARHGAP20 BMP2K NCOR1 CMIP ANKRD11 SLC4A4 | 4.13e-07 | 191 | 282 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | RIPOR2 CEP85L STK17A SYTL2 STAT4 TC2N RABGAP1L DOCK2 ANK3 SH2D2A | 4.13e-07 | 191 | 282 | 10 | 7f64add931b64b8d35836fa6bee9ebab593844d3 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | NEK10 PDK4 LRRTM3 RABGAP1L EXOC6B MTUS2 SOX6 ANK3 LMO7 MYOM2 | 4.13e-07 | 191 | 282 | 10 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZNF148 TAB2 PSME4 NFE2L2 ARHGAP20 BMP2K NCOR1 CMIP ANKRD11 SLC4A4 | 4.13e-07 | 191 | 282 | 10 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-07 | 194 | 282 | 10 | 0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 4.76e-07 | 194 | 282 | 10 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | STK17A SYTL2 LYST STAT4 ABCB1 TC2N ARHGAP9 SH2D2A VPS37B GAB3 | 4.76e-07 | 194 | 282 | 10 | 64535db0420e53e4d777d2333b5051e63e8a3373 |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | RIPOR2 PDK4 BACH1 GFRA2 JARID2 MAML3 DOCK2 CMIP KLF10 PLXDC2 | 4.99e-07 | 195 | 282 | 10 | 81a28289eda1a8a1a31b7357106f64ac5000e172 |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | DOK6 SSBP2 ARHGAP20 ANK3 FAM171B IGFBP5 PLXDC2 LMO7 CDH7 ARMH4 | 4.99e-07 | 195 | 282 | 10 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | TANC2 PTPRD RABGAP1L EXOC6B MAML3 ANK3 TTC28 DIP2C PAN3 GAB1 | 5.23e-07 | 196 | 282 | 10 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-07 | 198 | 282 | 10 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.74e-07 | 198 | 282 | 10 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.74e-07 | 198 | 282 | 10 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 5.74e-07 | 198 | 282 | 10 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.74e-07 | 198 | 282 | 10 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CYP2J2 PTPN13 TC2N MTUS1 PTPRZ1 ANK3 RUNX2 GRIP1 LMO7 SLC4A4 | 5.74e-07 | 198 | 282 | 10 | 6ba5e5970109a04ed968bac7ff099ae250c579dc |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA13 PTPN13 PTPRZ1 EDARADD FLRT3 SOX6 RASSF6 ASXL3 TNS1 CDH7 | 6.02e-07 | 199 | 282 | 10 | 94a7867e800df352731796de8c24cba133c29622 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 6.30e-07 | 200 | 282 | 10 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.30e-07 | 200 | 282 | 10 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | mild-NK|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ERBB2 SYTL2 DAB2 SSBP3 STAT4 ABCB1 HIPK2 ARHGAP9 SH2D2A MYOM2 | 6.30e-07 | 200 | 282 | 10 | e283c99cedb405802a51b895e2b0a09edbe49b2f |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.30e-07 | 200 | 282 | 10 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.30e-07 | 200 | 282 | 10 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.30e-07 | 200 | 282 | 10 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.30e-07 | 200 | 282 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.62e-07 | 162 | 282 | 9 | 3b89c3758835b7b9f9d4fb0bc8ed06da382fe48b | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.30e-06 | 168 | 282 | 9 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 170 | 282 | 9 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 170 | 282 | 9 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.66e-06 | 173 | 282 | 9 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 175 | 282 | 9 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.91e-06 | 176 | 282 | 9 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-06 | 177 | 282 | 9 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-06 | 178 | 282 | 9 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 178 | 282 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Adult-Immune-natural_killer_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.30e-06 | 180 | 282 | 9 | fc59e28f39e7d4fb1bcc7205202cf39224b70d7b | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-06 | 180 | 282 | 9 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | severe-CD8+_T_naive|World / disease stage, cell group and cell class | 2.41e-06 | 181 | 282 | 9 | 69eeeb7f326e230b07495d557f708fbe3312ac0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-06 | 181 | 282 | 9 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 181 | 282 | 9 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-06 | 181 | 282 | 9 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 2.52e-06 | 182 | 282 | 9 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.76e-06 | 184 | 282 | 9 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 3.02e-06 | 186 | 282 | 9 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.02e-06 | 186 | 282 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 186 | 282 | 9 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-06 | 188 | 282 | 9 | f8e6247bedc0ba494c5bb551539cb8ba5a97f557 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.29e-06 | 188 | 282 | 9 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.29e-06 | 188 | 282 | 9 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-06 | 188 | 282 | 9 | 8155bc5476fc333bedcc78c5ddcc8e4912536caa | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 188 | 282 | 9 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 188 | 282 | 9 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 3.44e-06 | 189 | 282 | 9 | e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-06 | 190 | 282 | 9 | 05e6af222d0ad97cb69f399a96c9038f9dd989b9 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 190 | 282 | 9 | c8031df82c3662ce4140c850277987f7210e9bcd | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 190 | 282 | 9 | 326002d7f9de5e425cee76d9a0277f42d79058e2 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.59e-06 | 190 | 282 | 9 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.59e-06 | 190 | 282 | 9 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.75e-06 | 191 | 282 | 9 | 5696e2e2db7b898a1c7ab3582ae74cb712dd5bdf | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Control / Disease state, Lineage and Cell class | 3.75e-06 | 191 | 282 | 9 | 03b5c5e0941c3402ab3f48cbf3da2a027d110421 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 3.75e-06 | 191 | 282 | 9 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.75e-06 | 191 | 282 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.75e-06 | 191 | 282 | 9 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.75e-06 | 191 | 282 | 9 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.91e-06 | 192 | 282 | 9 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | Immune-natural_killer_cell|World / Lineage, Cell type, age group and donor | 3.91e-06 | 192 | 282 | 9 | 68121a6ef4115a93d87aad8802ef9b27d793d8c0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.91e-06 | 192 | 282 | 9 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; HL60; HT_HG-U133A | RIPOR2 CYP19A1 DAB2 NEK9 CBLIF GK2 RECQL5 RIPOR1 MAML3 FAT4 GPR19 DSCAM DEPDC5 MAPK11 | 1.60e-07 | 195 | 282 | 14 | 2132_UP |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | FOXJ2 TRPC1 RAD54L2 LYST NEK9 TDRD3 ZMIZ2 RECQL5 RIPOR1 DSCAM MED16 VPS13D MAPK11 JHY | 1.93e-07 | 198 | 282 | 14 | 7349_UP |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | DNAJB12 MAN2A2 CYP2J2 STK17A NEK9 MEF2D ZMIZ2 GPR19 DSCAM SLC13A3 TFR2 MAPK11 JHY | 1.10e-06 | 196 | 282 | 13 | 3732_UP |
| Drug | Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A | ABCA12 BCOR TDRD3 ALMS1 RABGAP1L RECQL5 NDST1 BAZ1B VPS13D IGFBP5 ATM OSMR MAPK11 | 1.23e-06 | 198 | 282 | 13 | 2799_DN |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | DCAF1 DNAJB12 MAN2A2 KIAA0319L NEK9 CLCN6 PRUNE2 ASCL1 BTBD7 MAPK11 SLC24A1 GAB1 AFF4 | 1.23e-06 | 198 | 282 | 13 | 3750_UP |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | FOXJ2 TRPC1 BACH1 ZMYM2 PTPN13 RIPOR1 DSCAM HIPK2 VPS13D IGFBP5 IRAK4 CABIN1 TP53BP2 | 1.30e-06 | 199 | 282 | 13 | 6942_DN |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | ZHX3 KIAA0319L CBLIF CORO2B CLCN6 FLRT3 NDST1 MRAS VPS13D DEPDC5 SLC24A1 GAB1 | 5.27e-06 | 192 | 282 | 12 | 5620_UP |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A | TRPC1 NEK9 MEF2D CLCN7 RECQL5 EXOC6B PRUNE2 HIPK2 VPS13D SCARB1 SLC4A4 JHY | 5.56e-06 | 193 | 282 | 12 | 3200_DN |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | DNAJB12 ZHX3 KIAA0319L TTC28 BMP2K BAZ1B BTBD7 ATM MAPK11 CABIN1 GAB1 JHY | 6.51e-06 | 196 | 282 | 12 | 5257_DN |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | STK17A KIAA0319L CLCN6 CLCN7 NFATC3 RECQL5 GPR19 MED16 LRCH3 NCOR1 ZW10 AFF4 | 6.85e-06 | 197 | 282 | 12 | 5605_DN |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A | DNAJB12 IRF1 TAB2 JARID2 PTPN13 MTUS1 RABGAP1L BMP2K BAZ1B IRAK4 SLC24A1 CABIN1 | 7.22e-06 | 198 | 282 | 12 | 7279_UP |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A | ZMYM2 RXRA RABGAP1L MAD1L1 NDST1 BAZ1B RELA REV3L VPS13D IRAK4 SLC4A4 CDH7 | 7.22e-06 | 198 | 282 | 12 | 5885_DN |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | IRF1 MEF2D TDRD3 CLCN6 NFATC3 ZMIZ2 RECQL5 BMP2K DEPDC5 ZW10 SLC24A1 JHY | 7.22e-06 | 198 | 282 | 12 | 4370_DN |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | ERBB2 HEG1 MTUS1 NFKB1 MAD1L1 MPPE1 MPP1 BAZ1B ATP13A2 VPS13D ATM JHY | 7.60e-06 | 199 | 282 | 12 | 5817_DN |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A | DNAJB12 SART3 DAB2 DHX8 PER2 CLCN7 MTUS1 EXOC6B VPS37B VPS13D ASCL1 ENTPD6 | 7.60e-06 | 199 | 282 | 12 | 498_DN |
| Drug | Phycocyanin | 1.82e-05 | 27 | 282 | 5 | ctd:D010798 | |
| Drug | 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone | 1.85e-05 | 5 | 282 | 3 | ctd:C521815 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | ZHX3 ZSWIM8 ABCA12 NAGLU SSBP2 RXRA HEG1 BAZ1B SCARB1 ATM CABIN1 | 2.53e-05 | 189 | 282 | 11 | 5208_DN |
| Drug | Cosopt | KLF8 ERBB2 NFASC IRF1 STAT5A PER2 NFE2L2 NFKB1 HERC2 ARHGAP9 RELA RUNX2 CREBBP NCOR1 ITSN2 | 2.55e-05 | 341 | 282 | 15 | CID000003154 |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | TANC2 SART3 KIAA0319L ZMYM2 LYST ALMS1 FLRT3 HIPK2 BAZ1B ATM CDH7 | 2.79e-05 | 191 | 282 | 11 | 4283_DN |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | ZHX3 PDK4 KIAA0319L RXRA MEF2D PER2 CLCN6 VPS13D IGFBP5 BTBD7 TNS1 | 2.79e-05 | 191 | 282 | 11 | 3803_DN |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | CYP2J2 TRPC1 KIAA0319L SSBP2 ZMIZ2 NDST1 MED16 IGFBP5 LMO7 SCARB1 SYMPK | 2.93e-05 | 192 | 282 | 11 | 6639_DN |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | DNAJB12 ABCA12 PDK4 KIAA0319L TDRD3 HEG1 CLCN7 NFATC3 ZW10 SLC4A4 JHY | 3.07e-05 | 193 | 282 | 11 | 5628_DN |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; PC3; HT_HG-U133A | DCAF1 ZHX3 PDK4 KIAA0319L CNIH3 PSME4 CLCN7 NFATC3 LMO7 ATM TNS1 | 3.07e-05 | 193 | 282 | 11 | 4477_UP |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | ERBB2 MAN2A2 NAGLU MPPE1 GPR19 MED16 REV3L ATP13A2 ATM SLC24A1 CABIN1 | 3.07e-05 | 193 | 282 | 11 | 7014_DN |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | TRPC1 STAT4 ALMS1 CLCN6 NDST1 PGLYRP4 TFR2 ATM SLC4A4 SLC24A1 CABIN1 | 3.07e-05 | 193 | 282 | 11 | 3296_UP |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | RIPOR2 KIAA0319L ALMS1 CLCN6 ZMIZ2 FOXG1 HIPK2 DEPDC5 ATM OSMR SLC24A1 | 3.22e-05 | 194 | 282 | 11 | 3308_UP |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | SPTLC3 MAN2A2 KIAA0319L CNIH3 NFATC3 MRAS BTBD7 CEP41 ATM OSMR GAB1 | 3.22e-05 | 194 | 282 | 11 | 3345_UP |
| Drug | Vanadates | TANC2 SPTLC3 PRTG GAPVD1 NAPEPLD CEP85L STK17A SYTL2 DAB2 BBS2 NFASC STAT5A DHX8 ABCB1 JARID2 JUP CORO2B PER2 NFKB1 RIPOR1 ARHGAP20 MPP1 SH3TC2 TTC28 RELA RUNX2 ECPAS FIGN M1AP KLF10 GPR137C DIP2C SLC4A4 CDH4 | 3.34e-05 | 1302 | 282 | 34 | ctd:D014638 |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A | SPTLC3 IRF1 PSME4 PER2 CLCN6 RABGAP1L NDST1 ANK3 BAZ1B IGFBP5 ATM | 3.38e-05 | 195 | 282 | 11 | 4686_DN |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | A2M TRPC1 KIAA0319L DAB2 MEF2D FAT4 MRAS SLC13A3 ATM SLC24A1 CABIN1 | 3.54e-05 | 196 | 282 | 11 | 5253_UP |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; MCF7; HT_HG-U133A | A2M DAB2 RAD54L2 NEK9 MEF2D HEG1 PER2 EXOC6B IGFBP5 MAPK11 JHY | 3.54e-05 | 196 | 282 | 11 | 4381_DN |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A | SPTLC3 PDK4 NAGLU KIAA0319L RAD54L2 ECPAS VPS13D IGFBP5 BTBD7 TNS1 JHY | 3.54e-05 | 196 | 282 | 11 | 6744_DN |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; PC3; HT_HG-U133A | DCHS2 STAT5A GK2 CLCN7 NFATC3 RABGAP1L MED16 CREBBP MAPK11 SLC24A1 TNS1 | 3.54e-05 | 196 | 282 | 11 | 4066_UP |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | DNAJB12 NEK9 MEF2D ZMIZ2 GPR19 SH2D2A SCARB1 ZW10 SLC4A4 TNS1 GAB1 | 3.54e-05 | 196 | 282 | 11 | 4491_DN |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | ZHX3 MAN2A2 TRPC1 RXRA CLCN6 MTUS1 RABGAP1L RECQL5 TTC28 BMP2K ENTPD6 | 3.54e-05 | 196 | 282 | 11 | 7092_UP |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | DNAJB12 STK17A NAGLU KIAA0319L RAD54L2 TDRD3 GPR19 TTC28 MED16 ATM CABIN1 | 3.54e-05 | 196 | 282 | 11 | 3881_DN |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | ZHX3 CLCN6 ZMIZ2 RABGAP1L NDST1 DSCAM BAZ1B VPS13D IGFBP5 BTBD7 ATM | 3.54e-05 | 196 | 282 | 11 | 4697_DN |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | DNAJB12 ERBB2 TRPC1 KIAA0319L ZMIZ2 NDST1 TFR2 BTBD7 MAPK11 SLC24A1 CABIN1 | 3.71e-05 | 197 | 282 | 11 | 2888_UP |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | DNAJB12 ZHX3 NEK9 CLCN6 MTUS1 DSCAM BMP2K ATP13A2 BTBD7 CABIN1 SYMPK | 3.71e-05 | 197 | 282 | 11 | 2307_DN |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | DNAJB12 ZHX3 ZMIZ2 RABGAP1L GPR19 DSCAM BMP2K VPS13D IRAK4 CEP41 SLC4A4 | 3.71e-05 | 197 | 282 | 11 | 3692_DN |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | DNAJB12 NCKAP1 PSME4 CLCN6 CLCN7 ZMIZ2 RABGAP1L EXOC6B ANK3 DSCAM ATM | 3.71e-05 | 197 | 282 | 11 | 3270_DN |
| Drug | Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | DCAF1 DNAJB12 NAGLU IRF1 RAD54L2 TTC28 SLC13A3 IGFBP5 CABIN1 TNS1 AFF4 | 3.71e-05 | 197 | 282 | 11 | 6249_UP |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | A2M CYP2J2 INTS1 LYST DHX8 CLCN7 MPPE1 GPR19 SLC13A3 IGFBP5 ATM | 3.71e-05 | 197 | 282 | 11 | 335_DN |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | ZHX3 KIAA0319L RAD54L2 NFATC3 RECQL5 PRUNE2 HIPK2 IGFBP5 CEP41 DEPDC5 CABIN1 | 3.71e-05 | 197 | 282 | 11 | 4955_UP |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | DCAF1 TRPC1 ZMYM2 IRF1 NDST1 ANK3 TTC28 SLC13A3 IRAK4 SLC24A1 JHY | 3.71e-05 | 197 | 282 | 11 | 6271_UP |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | DNAJB12 HEG1 CLCN6 NFATC3 UBAP2L ZMIZ2 FOXG1 PRUNE2 PGLYRP4 BAZ1B ATM | 3.71e-05 | 197 | 282 | 11 | 3307_UP |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; PC3; HT_HG-U133A | A2M DNAJB12 ZSWIM8 MAN2A2 STK17A MTUS1 SCN4A SH3TC2 MAPK11 GAB1 JHY | 3.71e-05 | 197 | 282 | 11 | 6723_UP |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | ZMYM2 SSBP2 LYST TDRD3 UBAP2L NDST1 ANK3 DSCAM TTC28 BAZ1B IGFBP5 | 3.71e-05 | 197 | 282 | 11 | 6949_DN |
| Drug | Diazoxide [364-98-7]; Up 200; 17.4uM; MCF7; HT_HG-U133A | DCAF1 DNAJB12 BCOR RXRA RECQL5 SEC22A NCOR1 ATM OSMR ZW10 MAPK11 | 3.71e-05 | 197 | 282 | 11 | 7168_UP |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | SPTLC3 ERBB2 INTS1 UBAP2L MAD1L1 MPPE1 NDST1 BMP2K VPS13D CABIN1 TNS1 | 3.88e-05 | 198 | 282 | 11 | 6353_DN |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | DCAF1 CYP19A1 NEK9 MEF2D GK2 CLCN6 RECQL5 DSCAM MED16 IRAK4 GAB1 | 3.88e-05 | 198 | 282 | 11 | 4251_UP |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | A2M DCAF1 DNAJB12 GK2 NFATC3 RECQL5 HIPK2 BAZ1B IGFBP5 CCDC87 JHY | 3.88e-05 | 198 | 282 | 11 | 6777_UP |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | ZNF148 TAB2 NEK9 MPP1 SH3TC2 BMP2K CHD8 RELA IGFBP5 OSMR CABIN1 | 3.88e-05 | 198 | 282 | 11 | 4609_DN |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | SPTLC3 ZHX3 ABCA12 HEG1 NFATC3 RECQL5 RIPOR1 TTC28 ECPAS VPS13D BTBD7 | 3.88e-05 | 198 | 282 | 11 | 5684_DN |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A | ZSWIM8 ITIH3 CNIH3 RECQL5 SCN4A PRUNE2 CREBBP ASCL1 ATM MAPK11 GAB1 | 3.88e-05 | 198 | 282 | 11 | 3883_UP |
| Drug | quercetin dihydrate; Down 200; 1uM; MCF7; HT_HG-U133A_EA | DNAJB12 ZHX3 KIAA0319L TDRD3 ALMS1 UBAP2L ZMIZ2 ATP13A2 BTBD7 SCARB1 ATM | 3.88e-05 | 198 | 282 | 11 | 917_DN |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; PC3; HT_HG-U133A | ZHX3 ERBB2 IRF1 DHX8 MAD1L1 MPPE1 NDST1 KDM4A CABIN1 TNS1 JHY | 3.88e-05 | 198 | 282 | 11 | 6349_DN |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A | CYP2J2 TRPC1 CLCN6 CLCN7 RABGAP1L FOXG1 ANK3 VPS13D BTBD7 ATM AFF4 | 3.88e-05 | 198 | 282 | 11 | 3264_DN |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | ZHX3 TDRD3 CLCN6 ZMIZ2 FOXG1 BMP2K DEPDC5 ATM OSMR SLC24A1 JHY | 3.88e-05 | 198 | 282 | 11 | 4351_DN |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | DNAJB12 MAN2A2 ABCA12 KIAA0319L GAB2 TDRD3 CLCN7 RABGAP1L IGFBP5 BTBD7 ATM | 3.88e-05 | 198 | 282 | 11 | 1538_UP |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; MCF7; HT_HG-U133A | SPTLC3 RXRA NFATC3 UBAP2L RABGAP1L MAD1L1 GPR19 MED16 VPS13D IGFBP5 AFF4 | 4.07e-05 | 199 | 282 | 11 | 5498_DN |
| Drug | felodipine; Down 200; 10uM; MCF7; HG-U133A | A2M CYP2J2 NEK9 MEF2D GAB2 STAT5A DHX8 CLCN7 MPPE1 SLC13A3 ASCL1 | 4.07e-05 | 199 | 282 | 11 | 337_DN |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | TRPC1 GAB2 TDRD3 CLCN6 CLCN7 UBAP2L ZMIZ2 DSCAM NCOR1 IGFBP5 AFF4 | 4.07e-05 | 199 | 282 | 11 | 5426_DN |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | SPTLC3 PDK4 LYST F8 CLCN7 NFATC3 TTC28 BMP2K MED16 BTBD7 KDM4A | 4.07e-05 | 199 | 282 | 11 | 5634_DN |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; HL60; HT_HG-U133A | STK17A MEF2D MTUS1 NFATC3 RECQL5 RIPOR1 RELA SEC22A VPS13D DEPDC5 SYMPK | 4.07e-05 | 199 | 282 | 11 | 6126_DN |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; HL60; HT_HG-U133A | ZMYM2 RXRA GAB2 TDRD3 HEG1 MED16 CHD8 SCARB1 ENTPD6 TNS1 SYMPK | 4.07e-05 | 199 | 282 | 11 | 2132_DN |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | BACH1 STAT5A CLCN6 CLCN7 IMPG2 NDST1 MED16 HIPK2 TFR2 CEP41 JHY | 4.07e-05 | 199 | 282 | 11 | 5389_UP |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | ZHX3 ZSWIM8 RAD54L2 LYST NEK9 CLCN7 DSCAM TTC28 MED16 BAZ1B JHY | 4.07e-05 | 199 | 282 | 11 | 3203_DN |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; PC3; HT_HG-U133A | DNAJB12 STK17A CLCN7 MTUS1 ZMIZ2 IMPG2 MED16 LMO7 MAPK11 TNS1 CDH7 | 4.07e-05 | 199 | 282 | 11 | 5928_UP |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | ZSWIM8 RAD54L2 ALMS1 CLCN6 ZMIZ2 RIPOR1 PGLYRP4 DSCAM MED16 VPS13D SLC24A1 | 4.26e-05 | 200 | 282 | 11 | 3322_UP |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; HL60; HT_HG-U133A | RIPOR2 STK17A TRPC1 CLCN7 RECQL5 MED16 NR4A3 RUNX2 CREBBP IGFBP5 ENTPD6 | 4.26e-05 | 200 | 282 | 11 | 3068_UP |
| Drug | Raloxifene Hydrochloride | ERBB2 RIPOR2 MAN2A2 CYP19A1 ZMYM2 SSBP2 F8 GFRA2 ABCB1 HEG1 PTPN13 PSME4 PER2 CLCN6 NFE2L1 NFKB1 SCN4A ANK3 NR4A3 RELA RUNX2 FAM171B CREBBP KLF10 CABIN1 | 7.09e-05 | 857 | 282 | 25 | ctd:D020849 |
| Drug | diphenyleneiodonium | 9.45e-05 | 115 | 282 | 8 | ctd:C007517 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | DNAJB12 TOGARAM1 IRS1 JARID2 NFE2L2 SEC24B MGA REV3L CREBBP TBK1 | 9.55e-05 | 182 | 282 | 10 | 3887_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | ZNF148 TAB2 JARID2 NFE2L2 SEC24B MGA DSCAM REV3L CREBBP ITSN2 | 9.99e-05 | 183 | 282 | 10 | 7498_DN |
| Drug | beta-hydroxyisovalerylshikonin | 1.01e-04 | 8 | 282 | 3 | ctd:C118460 | |
| Drug | tiagabine | 1.01e-04 | 8 | 282 | 3 | ctd:C059205 | |
| Drug | eriodictyol | 1.17e-04 | 21 | 282 | 4 | ctd:C007619 | |
| Drug | CID5458193 | 1.29e-04 | 90 | 282 | 7 | CID005458193 | |
| Drug | 18alpha-glycyrrhetinic acid | 1.30e-04 | 40 | 282 | 5 | ctd:C119129 | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.30e-04 | 189 | 282 | 10 | 973_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | NAGLU RXRA CBLIF CLCN7 SH3TC2 BAZ1B BTBD7 KDM4A SLC24A1 CABIN1 | 1.30e-04 | 189 | 282 | 10 | 1225_UP |
| Drug | 5707885; Down 200; 50uM; PC3; HT_HG-U133A | RAD54L2 MEF2D CBLIF PTPRD NFATC3 IMPG2 IGFBP5 BTBD7 CEP41 TNS1 | 1.42e-04 | 191 | 282 | 10 | 6390_DN |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A | SPTLC3 INTS1 NAGLU MTUS1 NR4A3 VPS13D SCARB1 ENTPD6 CABIN1 SYMPK | 1.42e-04 | 191 | 282 | 10 | 3123_DN |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | DNAJB12 NCKAP1 BACH1 KIAA0319L BCOR HEG1 CLCN6 NFATC3 LMO7 SLC24A1 | 1.48e-04 | 192 | 282 | 10 | 1207_UP |
| Drug | 6-fluorocholesterol | 1.53e-04 | 2 | 282 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 1.53e-04 | 2 | 282 | 2 | CID006454807 | |
| Drug | I 240 | 1.53e-04 | 2 | 282 | 2 | CID000066328 | |
| Drug | valspodar | 1.53e-04 | 2 | 282 | 2 | ctd:C070272 | |
| Drug | WR 33278 | 1.53e-04 | 2 | 282 | 2 | ctd:C045611 | |
| Drug | AC1L1C3U | 1.53e-04 | 2 | 282 | 2 | CID000001728 | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | A2M ABCA12 MEF2D TDRD3 ZMIZ2 RIPOR1 IGFBP5 DEPDC5 ATM SLC24A1 | 1.55e-04 | 193 | 282 | 10 | 4380_DN |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.55e-04 | 193 | 282 | 10 | 4834_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | KIAA0319L RAD54L2 RXRA CNIH3 ALMS1 MTUS1 UBAP2L VPS13D IGFBP5 KDM4A | 1.55e-04 | 193 | 282 | 10 | 7057_UP |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 1.55e-04 | 193 | 282 | 10 | 6946_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | ZSWIM8 SYTL2 LYST ALMS1 RIPOR1 MPPE1 GPR19 ATM MAPK11 CABIN1 | 1.55e-04 | 193 | 282 | 10 | 5566_DN |
| Drug | ICI 182,780 | ERBB2 CYP19A1 IRF1 IRS1 GAB2 ADGRL4 PSME4 GRB14 NCOR1 KLF10 IGFBP5 MAPK11 | 1.60e-04 | 272 | 282 | 12 | CID000104741 |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | ZHX3 STK17A INTS1 ALMS1 CLCN7 RIPOR1 VPS13D ATM OSMR SLC24A1 | 1.61e-04 | 194 | 282 | 10 | 5268_DN |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | ZSWIM8 CYP2J2 SYTL2 UBAP2L RIPOR1 NDST1 GPR19 NCOR1 KLF10 IGFBP5 | 1.61e-04 | 194 | 282 | 10 | 6933_DN |
| Disease | Disorder of eye | BBS2 BCOR ALMS1 USH2A IMPG2 COL11A2 PRPF8 ATP13A2 GRIP1 CEP41 SLC24A1 | 5.41e-06 | 212 | 275 | 11 | C0015397 |
| Disease | Malignant neoplasm of prostate | ERBB2 CYP19A1 NAGLU IRS1 SSBP2 RXRA KMT2C JUP NFE2L2 MAD1L1 CHD6 MGA TAF1L CREBBP NCOR1 ITSN2 IRAK4 ATM | 2.22e-05 | 616 | 275 | 18 | C0376358 |
| Disease | Prostatic Neoplasms | ERBB2 CYP19A1 NAGLU IRS1 SSBP2 RXRA KMT2C JUP NFE2L2 MAD1L1 CHD6 MGA TAF1L CREBBP NCOR1 ITSN2 IRAK4 ATM | 2.22e-05 | 616 | 275 | 18 | C0033578 |
| Disease | C-reactive protein measurement | ZSWIM8 DCHS2 NAGLU IRF1 HSF5 NFE2L2 ZMIZ2 NFKB1 SCN4A EXOC6B MAML3 NBPF3 SOX6 ANK3 BAZ1B GRB14 NCOR1 IGF2BP3 CMIP KLF10 ASCL1 OR4A15 SCARB1 ENTPD6 CDH4 AFF4 ARMH4 | 2.63e-05 | 1206 | 275 | 27 | EFO_0004458 |
| Disease | Neurodevelopmental Disorders | 2.71e-05 | 93 | 275 | 7 | C1535926 | |
| Disease | Adenoid Cystic Carcinoma | 4.33e-05 | 100 | 275 | 7 | C0010606 | |
| Disease | Secondary Biliary Cholangitis | 4.35e-05 | 42 | 275 | 5 | C0238065 | |
| Disease | Biliary cirrhosis | 4.35e-05 | 42 | 275 | 5 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 4.35e-05 | 42 | 275 | 5 | C4551595 | |
| Disease | age at menarche | DNAJB12 CYP19A1 TRPC6 SSBP3 GAB2 PTPRD ALMS1 MAD1L1 TNRC6A FOXO3 DSCAM TTC28 ECPAS CMIP KDM4A PAN3 JHY | 4.85e-05 | 594 | 275 | 17 | EFO_0004703 |
| Disease | Primary biliary cirrhosis | 7.55e-05 | 47 | 275 | 5 | C0008312 | |
| Disease | Liver carcinoma | A2M PDK4 IRS1 ITIH3 STAT4 ABCB1 KMT2C MTUS1 NFE2L2 PZP IGF2BP3 CNTNAP4 DEPDC5 ATM AADAT | 9.36e-05 | 507 | 275 | 15 | C2239176 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.47e-05 | 152 | 275 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Adenocarcinoma | 1.11e-04 | 116 | 275 | 7 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 1.11e-04 | 116 | 275 | 7 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.11e-04 | 116 | 275 | 7 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.11e-04 | 116 | 275 | 7 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.11e-04 | 116 | 275 | 7 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.11e-04 | 116 | 275 | 7 | C0205641 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.27e-04 | 28 | 275 | 4 | DOID:3717 (is_marker_for) | |
| Disease | Autism Spectrum Disorders | 1.47e-04 | 85 | 275 | 6 | C1510586 | |
| Disease | waist-hip ratio | ZHX3 C2orf69 CYP19A1 SYTL2 NAGLU DAB2 PTPRD ZNRF3 SCN4A TNRC6A MAML3 FOXO3 PRUNE2 NDST1 MRAS ANK3 TTC28 HECTD4 SLC13A3 FIGN ATP13A2 PHC1 TBX18 CMIP SYMPK | 2.26e-04 | 1226 | 275 | 25 | EFO_0004343 |
| Disease | lymphocyte count | RIPOR2 IRF1 MS4A12 ERVW-1 LYST GFRA2 GAB2 ADGRL4 JARID2 PSME4 ALMS1 ZNRF3 NFKB1 RIPOR1 USP50 DOCK2 SH3TC2 TTC28 ICAM3 HECTD4 GRB14 TFR2 NCOR1 CMIP SCARB1 ANKRD11 ATM NEURL4 | 2.70e-04 | 1464 | 275 | 28 | EFO_0004587 |
| Disease | mean arterial pressure | BBS2 RXRA PTPRD CLCN6 ZNRF3 TNRC6A FGD5 SOX6 SH3TC2 HECTD4 HIPK2 FIGN CMIP TNS1 | 2.74e-04 | 499 | 275 | 14 | EFO_0006340 |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 2.84e-04 | 62 | 275 | 5 | EFO_0803360, EFO_0803362 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.39e-04 | 139 | 275 | 7 | DOID:3908 (is_implicated_in) | |
| Disease | response to triptolide, cytotoxicity measurement | 4.10e-04 | 16 | 275 | 3 | EFO_0006952, EFO_0007662 | |
| Disease | neuroimaging measurement | ZHX3 DCHS2 PRTG NAGLU SSBP3 ALX4 ZNRF3 TNRC6A FOXG1 FOXO3 PDPR ANK3 FAT3 KTN1 SLC13A3 REV3L RUNX2 ATP13A2 NCOR1 ASCL1 ENTPD6 TNS1 | 4.76e-04 | 1069 | 275 | 22 | EFO_0004346 |
| Disease | myocardial infarction | DOK6 ZHX3 BACH1 MAD1L1 FGD5 MRAS HECTD4 FIGN SCARB1 TNS1 ARMH4 | 4.85e-04 | 350 | 275 | 11 | EFO_0000612 |
| Disease | Carcinoma in situ of stomach | 4.94e-04 | 17 | 275 | 3 | C0154060 | |
| Disease | Benign neoplasm of stomach | 4.94e-04 | 17 | 275 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.94e-04 | 17 | 275 | 3 | C0496905 | |
| Disease | Malignant neoplasm of breast | ERBB2 CEP85L CYP19A1 STAT4 STAT5A ABCB1 PTPRD PER2 FGD5 HERC2 KTN1 RELA NCOR1 NSUN6 IGFBP5 ITSN2 DIP2C ATM TNS1 GAB1 TP53BP2 DOP1A | 5.07e-04 | 1074 | 275 | 22 | C0006142 |
| Disease | Carcinoma, Transitional Cell | 5.70e-04 | 41 | 275 | 4 | C0007138 | |
| Disease | stomach cancer (is_implicated_in) | 5.70e-04 | 72 | 275 | 5 | DOID:10534 (is_implicated_in) | |
| Disease | migraine disorder | SSBP2 MEF2D GFRA2 PTPRD RABGAP1L BAZ1B REV3L KLF10 DIP2C CDH4 ARMH4 | 5.71e-04 | 357 | 275 | 11 | MONDO_0005277 |
| Disease | Breast Carcinoma | ERBB2 CYP19A1 STAT5A ABCB1 PTPRD FGD5 HERC2 RELA NCOR1 NSUN6 IGFBP5 ITSN2 ATM TP53BP2 | 5.79e-04 | 538 | 275 | 14 | C0678222 |
| Disease | serum metabolite measurement | TANC2 IRF1 ALMS1 RABGAP1L EXOC6B ARHGAP20 RIC1 NBPF3 SOX6 SH3TC2 DDR2 SLC13A3 REV3L C2orf78 SCARB1 OR56A5 DIP2C MYOM2 MEGF11 ARMH4 | 6.08e-04 | 945 | 275 | 20 | EFO_0005653 |
| Disease | breast carcinoma | DOK6 NAPEPLD MCM8 NEK10 CYP19A1 BBS2 IRF1 TAB2 SSBP2 ALX4 PTPRD ZNRF3 SH3TC2 TTC28 TBX18 IGF2BP3 CCDC87 NBPF10 PADI6 TNS1 GAB1 | 6.28e-04 | 1019 | 275 | 21 | EFO_0000305 |
| Disease | intellectual disability (implicated_via_orthology) | 6.87e-04 | 75 | 275 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | amino acid measurement | TANC2 DOK6 CYP2J2 ABCA12 ALX4 ALMS1 RABGAP1L SCN4A MTUS2 SOX6 FAT4 GRB14 ARHGAP9 M1AP TBX18 AADAT | 6.88e-04 | 678 | 275 | 16 | EFO_0005134 |
| Disease | brain measurement, neuroimaging measurement | ZHX3 DCHS2 PRTG SSBP3 ALX4 TNRC6A FOXO3 ANK3 FAT3 KTN1 RUNX2 ATP13A2 ENTPD6 TNS1 | 7.17e-04 | 550 | 275 | 14 | EFO_0004346, EFO_0004464 |
| Disease | anti-Mullerian hormone measurement | 8.12e-04 | 20 | 275 | 3 | EFO_0004769 | |
| Disease | testosterone measurement | ZHX3 DCHS2 KLF8 NHSL2 CYP19A1 RXRA GFRA2 SHROOM4 NFE2L2 NFKB1 USH2A SOX6 MRAS ANK3 DSCAM TTC28 BAZ1B GRB14 ARHGAP9 CMIP ASCL1 SCARB1 SLC24A1 JHY | 9.27e-04 | 1275 | 275 | 24 | EFO_0004908 |
| Disease | Stomach Carcinoma | 9.40e-04 | 21 | 275 | 3 | C0699791 | |
| Disease | complement factor H-related protein 3 measurement | 1.08e-03 | 169 | 275 | 7 | EFO_0600056 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.12e-03 | 49 | 275 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | thalamus volume | 1.21e-03 | 85 | 275 | 5 | EFO_0006935 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 1.27e-03 | 6 | 275 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | lymphoma (is_implicated_in) | 1.27e-03 | 6 | 275 | 2 | DOID:0060058 (is_implicated_in) | |
| Disease | Carcinoma, Lobular | 1.27e-03 | 6 | 275 | 2 | C0206692 | |
| Disease | pulse pressure measurement | KLF8 NCKAP1 NEK10 NEK9 ITIH3 DHX8 JUP PTPRD CLCN6 NFE2L2 EDARADD TNRC6A FGD5 USP50 SOX6 FOXO3 GPR19 PDPR DSCAM TTC28 FAT3 FIGN TBX18 PLXDC2 ANKRD11 | 1.40e-03 | 1392 | 275 | 25 | EFO_0005763 |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 1.40e-03 | 24 | 275 | 3 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | stomach carcinoma (is_marker_for) | 1.40e-03 | 24 | 275 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | ERBB2 CYP19A1 STAT5A ABCB1 PTPRD FGD5 RELA NCOR1 NSUN6 IGFBP5 ITSN2 ATM TP53BP2 | 1.41e-03 | 525 | 275 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | ERBB2 CYP19A1 STAT5A ABCB1 PTPRD FGD5 RELA NCOR1 NSUN6 IGFBP5 ITSN2 ATM TP53BP2 | 1.41e-03 | 525 | 275 | 13 | C1257931 |
| Disease | Mammary Neoplasms | ERBB2 CYP19A1 STAT5A ABCB1 PTPRD FGD5 RELA NCOR1 NSUN6 IGFBP5 ITSN2 ATM TP53BP2 | 1.46e-03 | 527 | 275 | 13 | C1458155 |
| Disease | glucose-dependent insulinotropic peptide measurement | 1.51e-03 | 53 | 275 | 4 | EFO_0008464 | |
| Disease | Small cell carcinoma of lung | 1.62e-03 | 54 | 275 | 4 | C0149925 | |
| Disease | chronic mucus hypersecretion | 1.76e-03 | 7 | 275 | 2 | EFO_0005673 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.76e-03 | 7 | 275 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | invasive lobular carcinoma (is_marker_for) | 1.76e-03 | 7 | 275 | 2 | DOID:3457 (is_marker_for) | |
| Disease | retinal detachment | 1.76e-03 | 7 | 275 | 2 | EFO_0005773 | |
| Disease | body weight | C2orf69 GAPVD1 CYP19A1 DAB2 BBS2 IRS1 SSBP2 SSBP3 ZMIZ2 RABGAP1L TNRC6A MGA MAML3 FOXO3 MRAS HECTD4 GRB14 CHD8 NCOR1 IGF2BP3 ASXL3 CNTNAP4 CDH7 | 1.78e-03 | 1261 | 275 | 23 | EFO_0004338 |
| Disease | ovarian cancer (is_implicated_in) | 1.85e-03 | 56 | 275 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | Profound Mental Retardation | 1.98e-03 | 139 | 275 | 6 | C0020796 | |
| Disease | Mental deficiency | 1.98e-03 | 139 | 275 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.98e-03 | 139 | 275 | 6 | C0025363 | |
| Disease | Squamous cell carcinoma of esophagus | 1.98e-03 | 95 | 275 | 5 | C0279626 | |
| Disease | Bladder Neoplasm | 2.06e-03 | 140 | 275 | 6 | C0005695 | |
| Disease | cognitive function measurement | TANC2 DNAJB12 SSBP2 RXRA GFRA2 ADGRL4 PTPRD ALMS1 ZMIZ2 RABGAP1L MAD1L1 TNRC6A USH2A MAML3 PUS7 FOXO3 DSCAM TTC28 ARHGAP9 FIGN ITSN2 CNTNAP4 MAPK11 CDH4 CDH7 | 2.08e-03 | 1434 | 275 | 25 | EFO_0008354 |
| Disease | Malignant neoplasm of urinary bladder | 2.13e-03 | 141 | 275 | 6 | C0005684 | |
| Disease | age at menopause | 2.23e-03 | 302 | 275 | 9 | EFO_0004704 | |
| Disease | mean arterial pressure, alcohol drinking | 2.27e-03 | 98 | 275 | 5 | EFO_0004329, EFO_0006340 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 2.34e-03 | 8 | 275 | 2 | DOID:5520 (is_marker_for) | |
| Disease | JT interval | 2.39e-03 | 248 | 275 | 8 | EFO_0007885 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.39e-03 | 60 | 275 | 4 | C4722327 | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.48e-03 | 100 | 275 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 2.70e-03 | 30 | 275 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.71e-03 | 148 | 275 | 6 | C0279702 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.86e-03 | 63 | 275 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | Experimental Autoimmune Encephalomyelitis | 2.98e-03 | 9 | 275 | 2 | C0014072 | |
| Disease | Hepatic Insufficiency | 2.98e-03 | 9 | 275 | 2 | C1306571 | |
| Disease | arterial stiffness measurement | 3.02e-03 | 64 | 275 | 4 | EFO_0004517 | |
| Disease | smoking status measurement | GAPVD1 GAB2 GK2 PTPRD ALMS1 UBAP2L MAD1L1 TNRC6A HERC1 USH2A MAML3 FOXO3 FAT3 HECTD4 REV3L FIGN ENTPD6 CNTNAP4 KDM4A MEGF11 ARMH4 | 3.04e-03 | 1160 | 275 | 21 | EFO_0006527 |
| Disease | intraocular pressure measurement | PRTG RXRA GAB2 ADSS2 ZNRF3 HERC2 ARHGAP20 RUNX2 ATP13A2 LMO7 OR4A15 TNS1 | 3.17e-03 | 509 | 275 | 12 | EFO_0004695 |
| Disease | Squamous cell carcinoma of lung | 3.25e-03 | 32 | 275 | 3 | C0149782 | |
| Disease | asthma, response to diisocyanate | 3.26e-03 | 261 | 275 | 8 | EFO_0006995, MONDO_0004979 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.31e-03 | 206 | 275 | 7 | C0152013 | |
| Disease | Intellectual Disability | TANC2 KLF8 NAGLU ZMYM2 SHROOM4 KMT2C FOXG1 PUS7 NDST1 CHD8 ASCL1 | 3.37e-03 | 447 | 275 | 11 | C3714756 |
| Disease | Dupuytren Contracture | 3.46e-03 | 108 | 275 | 5 | EFO_0004229 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.46e-03 | 108 | 275 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | unipolar depression, bipolar disorder | 3.52e-03 | 156 | 275 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | C-X-C motif chemokine 10 measurement | 3.60e-03 | 109 | 275 | 5 | EFO_0008056 | |
| Disease | Epilepsy | 3.60e-03 | 109 | 275 | 5 | C0014544 | |
| Disease | smoking cessation | 3.63e-03 | 325 | 275 | 9 | EFO_0004319 | |
| Disease | Hashish Abuse | 3.71e-03 | 10 | 275 | 2 | C0018614 | |
| Disease | Cannabis Abuse | 3.71e-03 | 10 | 275 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 3.71e-03 | 10 | 275 | 2 | C0236735 | |
| Disease | Facies | 3.71e-03 | 10 | 275 | 2 | C0282631 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPPDSDTVGMDSSYL | 166 | Q9H161 | |
| ISVSMSSNPPTLYEL | 336 | Q9HBW9 | |
| LVTYNTDTFESMPNP | 271 | P04626 | |
| SPPLQDSASQTYESM | 196 | O14867 | |
| PYLRASFSSASPEQM | 396 | Q8N5Z0 | |
| PTPQDYEMRVSPSDT | 2036 | Q9HCK8 | |
| EVPTVSPNSRFTYHM | 71 | O42043 | |
| RQQSVPAASSYDSPM | 1811 | Q6UB99 | |
| SDESAMSFYPPSLND | 241 | Q8N8R5 | |
| YKTSDTNTMVPLYPS | 166 | A6NCI8 | |
| TNTMVPLYPSLSASL | 171 | A6NCI8 | |
| PSTAARESMPYTNAV | 351 | P51589 | |
| GPDMEQSNPAYTISA | 291 | Q6ZNE5 | |
| YSNTTSPPLETMTAQ | 286 | Q8IZF6 | |
| TNPSASPEYMFSSNI | 1321 | Q86UK0 | |
| PDAQYPITAVSLMEA | 626 | Q9UIG0 | |
| PSSYVNTKEMLTTNP | 206 | Q86TY3 | |
| CPMSVDQKDTTPYSS | 251 | Q96GX5 | |
| TATPLPSQYLMELSE | 31 | Q15760 | |
| PPIFSLNSYSTSLME | 1941 | Q6V0I7 | |
| PMETSNLYLFDETPV | 481 | Q9NZU0 | |
| MTDTPAVPSTFYSQR | 1086 | Q8TCU4 | |
| PIATLSRTMNPYSND | 196 | Q9BYV8 | |
| LASATPTGYMENSVS | 96 | Q8IY22 | |
| YPTPAMQGASSSVLA | 226 | Q92793 | |
| QPQSMPVTFLSSRSY | 366 | Q9C0A0 | |
| PYISSNSDIFSMSPS | 2606 | Q86UQ4 | |
| MDVDQTPSGLTAYIS | 131 | Q8WXA8 | |
| PAMETANITPSVYSV | 2021 | Q5JWR5 | |
| FPSASQVLAEPMTYK | 1936 | Q96M86 | |
| SASSTNPSMNFPINY | 1046 | Q9Y4B4 | |
| IDISSSQMVSLPSYP | 276 | Q9NVE4 | |
| SLPAQVGTIMDSSYS | 581 | Q9NSY1 | |
| ALSKPYMTVSSEFPA | 371 | Q6W2J9 | |
| AMETISVPSYPSKSA | 761 | Q13625 | |
| FTGNMLTINSYDSPP | 1416 | Q9C0F0 | |
| FYEPQAPSAEVEMTS | 1196 | P01023 | |
| QESKSPFPMYSETVD | 961 | Q9UHB7 | |
| EMQPPSSEPSYLAAA | 316 | P54802 | |
| TVNMTYQPTTPSSSF | 541 | Q5JR59 | |
| TYNMAPSALDSADLP | 576 | Q14494 | |
| MATSAVPSDNLPTYK | 1 | O14807 | |
| MVSYGVPNSSEETAT | 86 | P61574 | |
| DSDLYQMTAPLPNSA | 196 | P57052 | |
| SDSNSTEPQYMVLVP | 21 | P20742 | |
| GETSLNYVSQLASPM | 911 | Q99650 | |
| EPDSPVLYRTMSEAA | 176 | Q6ZTQ3 | |
| PDSTMIAVSTANGYI | 76 | Q4ADV7 | |
| FPSNYVKMTTDSDPS | 1176 | Q9NZM3 | |
| TSDLYNFQVSPMPST | 206 | P10914 | |
| PLIDSYSTEGLMPNT | 1016 | P08183 | |
| YSTAPTPVMDNSRNA | 311 | Q16654 | |
| ASSQPVSSEMYRDPF | 751 | P98082 | |
| AFYPQVSVDQTATPM | 1106 | O75140 | |
| EPSYAEGSQMSTSIP | 1736 | Q8WXI7 | |
| YLTETPLAVTPDFMQ | 4411 | Q8WXI7 | |
| YDPTFMPASAQSTKS | 6116 | Q8WXI7 | |
| TYATVKMTSPSPSVD | 81 | Q6TGC4 | |
| AYVMTSREPPLNTAA | 91 | Q9Y4B6 | |
| SPMYRMPDNSISNTN | 346 | Q5HY92 | |
| MGSPYTDVPSLSTSN | 971 | A6BM72 | |
| SSEHARTYIQSLPPM | 251 | Q15759 | |
| PDPDSLSSQFMAYIE | 396 | Q96II8 | |
| NSYEVSSAPDVPSMG | 4111 | Q8NEZ4 | |
| PSTLYQPSAASMAAV | 616 | Q9H2X6 | |
| LDISTSAPGSLQMQY | 31 | Q9Y6D9 | |
| SQRIPASTFYVIMPS | 376 | Q8TC57 | |
| APLYPSQETSMELSG | 161 | Q6NUN7 | |
| LNSEYSMAETLVGTP | 201 | Q8TD19 | |
| AAQSEMGLAPYSTTP | 851 | Q96JK9 | |
| TPQSMQSTLDRFIPY | 61 | Q9UJA3 | |
| MIPTTTKNNYSPTAA | 121 | O60721 | |
| SMGFSSNAPTSPVVY | 841 | Q8IWI9 | |
| VSLFTPLTAAEMAPY | 2036 | Q8N201 | |
| SNPFMSLKPEQVYSS | 411 | Q4VC12 | |
| PQVTPSEAQDMTYTA | 231 | Q9ULD2 | |
| YNNSEALPTSPMAPT | 371 | Q16832 | |
| IVDPADSSYMPSLVV | 2836 | O95714 | |
| TPTLQLSAMQEGDYT | 556 | Q8IZA0 | |
| SSFTEPIQEANYVPM | 461 | Q13480 | |
| MYPTASASIEDSYVP | 381 | Q8WWW8 | |
| SASIEDSYVPMSPQA | 386 | Q8WWW8 | |
| VSSPLPSYEQMVAAS | 261 | Q96MR6 | |
| SYTVTPHLNGPMTDT | 391 | Q8N3F9 | |
| KSSSLEMTPYNTPQL | 451 | Q14C86 | |
| LRQMFSSYPTTTVLP | 2681 | Q15751 | |
| YLPITSNFESGPQMS | 386 | Q8NDZ0 | |
| ATDPGIFSSPVYTNM | 476 | Q5CZC0 | |
| DLSEFMNPSPYTVPQ | 736 | P51798 | |
| MASIAKQTSSLVPPY | 1551 | Q5VYK3 | |
| NPSFIMGSITPTDYT | 331 | Q53F39 | |
| SHPMPYSSVLTQNSL | 336 | P55316 | |
| YPSHFNPAISTTLMS | 71 | Q9GZW8 | |
| TLTSEMASASQPEFP | 936 | O15055 | |
| SPPFYSTNMLSLATK | 726 | Q6ZWH5 | |
| YARPNSTFPIDKSMT | 286 | Q8NGL6 | |
| AVDVLSELSYAPMTP | 631 | Q8NCN5 | |
| PSPAALSAMENLITY | 161 | Q96LB8 | |
| YSAFIAEPSISNSMP | 286 | Q16236 | |
| FPSADTSDYENIPAM | 766 | Q6ZNL6 | |
| DVMTTGTTPDYQDPT | 281 | P13942 | |
| MHPDLSSNYPSSETF | 626 | P52848 | |
| DPPEIEYRSNMTSPT | 36 | O95600 | |
| ETLNPSARIMTFYPT | 6 | O75164 | |
| SSPQNTSHTIMTFYP | 6 | B2RXH2 | |
| MSLLPVPYTEAASLS | 1 | Q05315 | |
| PPTMTVSEASYQSER | 816 | Q8WWI1 | |
| TTYIPLMDNADSSPV | 231 | Q86UP2 | |
| EPTTSEMAEETYSPK | 121 | P24593 | |
| PSMPVHYDSQLDTTL | 926 | P00451 | |
| SDNYSPIPVTSEEMY | 451 | Q9Y2D4 | |
| MTDVYYSPTSVRNPE | 1326 | Q9ULI3 | |
| PQMSLQSPTSIASYS | 191 | Q9P0K8 | |
| IPSFNEMVYPSESTV | 1056 | P23471 | |
| GSMYTVTSLDNQPLA | 3146 | Q9Y4D8 | |
| YVDTSPAAPVSYADM | 1001 | P35568 | |
| IRMTEPVYLSPSFDS | 196 | Q8TEA1 | |
| PPSQGDLEYQMSTTA | 66 | P14923 | |
| SAMTPPYPQFEQSET | 391 | O00425 | |
| SLPTLASNVMSQYSP | 1006 | Q9Y2A7 | |
| ATMKSSSQYPFPVTL | 156 | Q5R372 | |
| VREESTYLPLTSMQP | 521 | P32942 | |
| TMAVFYSSAAPRPVD | 401 | Q9Y2X0 | |
| STSVAPMLNPFIYTL | 276 | A6NCV1 | |
| YCSSTVFLDTMPESP | 266 | Q8IV76 | |
| SPPRNATMAVYVSVT | 1271 | Q6V1P9 | |
| TVVMSEDRPSAPYNV | 411 | Q2VWP7 | |
| MTLPSNNSTSPVFEF | 1 | P0C7T3 | |
| YPTSTNSSAAFEMVP | 581 | Q9Y5I4 | |
| RMDPPCTNTTAASTY | 326 | P10619 | |
| PASYMVPSSASTSVN | 366 | Q58A45 | |
| ERTPSFMYPQGTASS | 241 | O94856 | |
| PPDMSASYQSDRSTF | 356 | Q9H094 | |
| PSYPEISFSCSMEQL | 161 | Q9UBI1 | |
| TTDPMLAYLQPFRTS | 1756 | Q13315 | |
| PETVPTDFAQMLQSY | 666 | Q9NQ11 | |
| VDVTPYMNPSPFTVS | 801 | P51797 | |
| VLMENSVTSSAYPNP | 41 | P27352 | |
| FSMYALTSLDPASEP | 481 | Q9BXC9 | |
| PSSPLANTTYNIFIM | 221 | A0A1B0GVN3 | |
| SDYQDPSQPLESSMV | 301 | Q9Y6J0 | |
| SDSYQEDIYPMTPGT | 361 | Q9UQ03 | |
| QPDYAMYSRISSSPT | 206 | Q92608 | |
| PMDLLPNVFSSSEIY | 226 | Q14410 | |
| YNITSIVPEAMPAAT | 11 | P11511 | |
| IGFDMTPNYVDSSPT | 301 | O00451 | |
| SSKMSRAQTFPSYAP | 291 | Q6PKX4 | |
| PTISPNYSNDLNSMA | 191 | P50553 | |
| SPMSDASVNFDYKSP | 21 | Q8TD26 | |
| ETPSGPESSVNMDLY | 541 | A2CJ06 | |
| APYPTSQMVSSDRSQ | 416 | Q6UUV7 | |
| ALSQLMVSSPPYSLS | 261 | Q9NXW2 | |
| MNDLRPLFSPTTYSV | 151 | Q8TDW7 | |
| ISIMDINEAPYFPSN | 496 | P55283 | |
| VQTSMDAYTPPDTSS | 121 | Q9Y2E4 | |
| EVFPMTSSGAPISEY | 756 | Q9Y2E4 | |
| SPKSNINMYSSSLPF | 1646 | Q12955 | |
| TAMPFSPLRSYVSAA | 1771 | Q12955 | |
| YSALPESKPIMTSSE | 256 | Q5SZL2 | |
| NSTPPAETMFTDLDS | 736 | Q9P203 | |
| EVPTVSPISRFTYNM | 181 | P61565 | |
| EVPTVSPNSRFTYHM | 71 | Q9HDB8 | |
| DTTMSPSQYLTFPLL | 1386 | Q99698 | |
| EPTLEVVEQASPYSM | 156 | A8MTA8 | |
| LASPSNSTDVYLEPM | 1126 | P49641 | |
| TDPSTLSFNMSDKYP | 31 | Q8WWZ3 | |
| YSPSDFEPSQVSNLM | 96 | Q13118 | |
| PTQILQMFLSSSTYP | 221 | Q14449 | |
| LEQSYMPPDSSSPEN | 141 | Q9NWZ3 | |
| NTVTEDMYTNGSPAP | 41 | Q00013 | |
| LIPFYVATSMTAPSN | 246 | Q3SXM5 | |
| VFSSPLYPMEVSEAT | 376 | Q9ULB5 | |
| FTYSSPTPDMEELQP | 446 | Q96LA5 | |
| SVNPELATMSYFHPS | 221 | Q9NQ60 | |
| LSDMYPSTVPSVDSA | 791 | Q9Y3R0 | |
| LPLSASTDYEQSTGM | 16 | Q96IW7 | |
| TSSASPMPNSYDALE | 396 | O95487 | |
| VFVSNLPYSMQEPDT | 706 | Q15020 | |
| DMYSVNVTALPPTLA | 581 | Q8WWT9 | |
| TETYVEANMGLNPSS | 246 | P19793 | |
| MPIYSSVTLSLFPQS | 156 | Q6P995 | |
| SSPDTTEPGYINIME | 116 | Q92613 | |
| TTHNPAYLQLPSTMT | 586 | Q96JN8 | |
| PVYSALPSEMQTRIF | 811 | Q14562 | |
| SQGLPFSSMPTAYNT | 321 | Q14814 | |
| TPSQPDDLLTFISYM | 2381 | Q12923 | |
| YATSPYSDPVVSMDL | 1241 | P23468 | |
| SPALPNSMVYFGSSQ | 166 | Q92833 | |
| FTTPAMTTAAPLTYV | 3991 | Q685J3 | |
| MYESNPVTPASSSAP | 241 | Q9NXJ0 | |
| SSPEDEVLPSTSMYF | 121 | Q92570 | |
| IPAMITSYPNTTLAT | 786 | O60469 | |
| VDNMDVPATPLSAYQ | 311 | Q9UQC2 | |
| VQDDDAPLSPMLYSS | 336 | O43524 | |
| APSAMCTPSYLSTAA | 676 | Q9P2F6 | |
| YLSQMTSPSIHSTTP | 306 | Q13950 | |
| TSSPYVSKSETHQPM | 396 | Q9HCH5 | |
| NPSMQSSYPVEFLPS | 341 | Q4G112 | |
| GSSASDDYIVQTPMS | 3756 | O75445 | |
| LSASFPMEESSINYT | 1621 | Q7Z3J3 | |
| SLSMDIIGDPSQAYT | 266 | Q5MJ70 | |
| PSPADSTNSGDNMYT | 256 | P81877 | |
| SFLVPPMTIYTEQDL | 291 | Q9UQF0 | |
| PSMPSIRHQDVYSTV | 256 | Q5T2D2 | |
| MPSPADSTNSSDNIY | 281 | Q9BWW4 | |
| MQLEDYTPTIPDAVT | 121 | Q12962 | |
| VEFSYMSKISLNTPP | 16 | Q9H7E2 | |
| PSTEEPASLYTEDMT | 621 | Q8WUY3 | |
| MAANPSKVSYEPITT | 1706 | P35499 | |
| APIPTFSTFQITDMT | 16 | Q9NP31 | |
| YSEPSMPSSQECLES | 376 | Q8N103 | |
| TVYIAASPPNTDELM | 366 | Q9NYJ8 | |
| LSTQEMDYSLDITPP | 331 | Q8N9U0 | |
| TQPQSSPFSCMDLTY | 421 | O75354 | |
| SMNVSTFLAYDQPTI | 516 | Q86VH5 | |
| TSPTAQMEAYVAEPR | 1016 | Q5HYW2 | |
| STLSIPPEMLASYQS | 566 | Q6P3W6 | |
| YTSQPPDMYDTNTSL | 1661 | Q8IZX4 | |
| EDAEATPVSPAMSYL | 621 | Q06033 | |
| SSTGSTQFPYNPLTM | 2376 | O75376 | |
| TQYIAPLMANFDPSV | 196 | Q6UX71 | |
| DFSLPPSTYATMAIR | 626 | Q96PZ0 | |
| SMSPLQSETPTYSEC | 846 | Q9ULL8 | |
| YQTETLPMILTSTSP | 141 | A0PJX4 | |
| MTPESSLEFYSPEAC | 266 | Q8WTV0 | |
| YLMPRPNSVAATSSA | 261 | Q9HCD6 | |
| VPTRNIDPDSYSPMS | 321 | Q8TF17 | |
| IDPDSYSPMSRNSAF | 326 | Q8TF17 | |
| SAVYASSMSPPIAEQ | 396 | Q9NUV7 | |
| NAMDVTFQPTPALTY | 1171 | P14410 | |
| MAFAETYPAASSLPN | 1 | P30520 | |
| DAVLPMSSSFYLDPQ | 1266 | Q9P2P6 | |
| VDAPRTPMDNYSQTT | 3941 | Q9P2P6 | |
| PSMEDSDVSLTSSPY | 546 | Q9BZV3 | |
| SPYTNSSRKQPMSAT | 36 | Q86XK3 | |
| SMYSQGTPETPTFKD | 341 | Q9Y4F9 | |
| APEILSYDPISMATD | 231 | Q9UEE5 | |
| DNYPVQFIPSTMAAA | 301 | P35712 | |
| SSATYMDQAPSPAVC | 716 | P42229 | |
| DSSELAYDPPVVMNA | 111 | Q8TBE1 | |
| LYITPEMAASSSFQP | 126 | O94762 | |
| DYTTDNMSIYPSPTG | 1686 | Q6P2Q9 | |
| NPEYSTTMDVAPVIL | 151 | P48995 | |
| DPLEGSSVSTMTSQY | 361 | Q8N7U7 | |
| EPVPTATTMATYQDS | 76 | Q9UPR6 | |
| PFLVPMISYAASSET | 161 | Q7RTX1 | |
| DMGSTTQSPSLVQYD | 391 | Q14157 | |
| PLIMEPESRFYSNSV | 2596 | O60673 | |
| ESTSPVQSMLDAYFP | 301 | Q96AG3 | |
| MLFATPPSSTYEKAL | 231 | Q96DB5 | |
| GEPSLYNSLSIAMQT | 141 | Q13888 | |
| LQYIMPSPSSNAFAT | 496 | O95935 | |
| PCPISISYEMSDSQD | 11 | Q5MJ68 | |
| ISYEMSDSQDPTTSP | 16 | Q5MJ68 | |
| NLSPTTIETAMKSPY | 731 | Q14765 | |
| AMVADNSLYDPESPV | 136 | Q8IUW5 | |
| RSPSPSQYSMVSDAE | 31 | Q5VZP5 | |
| SFAYMPPTSEAASSL | 181 | O15533 | |
| DFSKYSMPDNSPETR | 1436 | Q9HBL0 | |
| SDSEMITQLLAYTPP | 146 | Q06203 | |
| FPYPTMSEITVLSAQ | 306 | Q9UKY1 | |
| IPQTYASMVTSSHLP | 751 | Q12968 | |
| VYATLPTSSQGTEME | 96 | A8MV23 | |
| MTSQPSLPADDFDIY | 1 | Q70EL3 | |
| TSSPVVAQVPAAFYM | 611 | P78364 | |
| AYMIEESIPSQSPTT | 81 | Q9BRR9 | |
| MPTTGPNSLSYASSA | 201 | O95473 | |
| YIFMIDVSLPNTTPT | 1511 | Q14997 | |
| MPASFQAIYTPVESA | 426 | Q92797 | |
| SSSVPYMSPNQEVKS | 381 | Q8NF64 | |
| QSSMYSLPNAPTLAD | 106 | Q68CL5 | |
| NSDPETQSSMPDVPY | 986 | Q9UBW7 | |
| VNSMYLSSTEPPAAA | 316 | A7E2V4 | |
| KNPPTYSSSTSMAAV | 1471 | Q96AY4 | |
| YENFMTETPELPSTC | 971 | Q86YA3 | |
| NAIPAYPTRTSMDSH | 376 | Q9ULT6 | |
| NDTTLAPEYLPTMSS | 641 | Q9Y6R1 | |
| PAFSSIDKQVYATMP | 641 | Q9UQR1 | |
| ASPAYLSLSSEDPVM | 281 | Q9Y210 | |
| MASESETPTGAISQY | 1216 | Q9Y4F4 | |
| SHTTTPMVTYPIASQ | 411 | Q96K80 | |
| TPFTAAMSSGQAVPY | 221 | Q9H9H4 | |
| SPPVSNSYTQADPMA | 711 | Q6ZS17 | |
| STINYDEFPTMVFPS | 356 | Q04206 | |
| IPLSSIPTYNAAMDS | 301 | Q9H4I2 | |
| VIRPLPMDSSAYSFT | 561 | Q9UP52 | |
| RDPSQSSDAMYVVVP | 71 | Q9BZD7 | |
| FVPYDFMNSSTSPAS | 1571 | Q8NDV7 | |
| HTMTPIYPSSNTLVE | 671 | Q9UHD2 | |
| RFESIMTNLEYPSPS | 276 | O43264 | |
| MTNLEYPSPSEVFTK | 281 | O43264 | |
| AQTQSSLFYSPSSPM | 1506 | Q9BYP7 | |
| TTQPFMLYVTPLSNE | 3886 | Q5THJ4 | |
| SQKALPTSPTEYQMA | 536 | Q8N5Q1 | |
| PNTTTESPVMGYFVD | 406 | P54296 | |
| TDPIFSSRASPSQYM | 146 | Q6IQ20 | |
| SPAPSKTLMDNYEVS | 851 | P19838 |